Search
Cisplatin Treatment Options in Canada
A collection of 326 research studies where Cisplatin is the interventional treatment. These studies are located in the Canada . Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-small Cell Lung Cancer.
121 - 132 of 326
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
Active Not Recruiting
The purpose of this study is to assess the antitumor efficacy and safety of perioperative enfortumab vedotin (EV) plus pembrolizumab and radical cystectomy (RC) + pelvic lymph node dissection (PLND) compared with the current standard of care (neoadjuvant chemotherapy \[gemcitabine plus cisplatin\] and RC + PLND) for participants with MIBC who are cisplatin-eligible. The primary hypothesis is perioperative EV and pembrolizumab and RC + PLND (Arm A) will achieve superior event free survival (EFS)... Read More
The purpose of this study is to assess the antitumor efficacy and safety of perioperative enfortumab vedotin (EV) plus pembrolizumab and radical cystectomy (RC) + pelvic lymph node dissection (PLND) compared with the current standard of care (neoadjuvant chemotherapy \[gemcitabine plus cisplatin\] and RC + PLND) for participants with MIBC who are cisplatin-eligible. The primary hypothesis is perioperative EV and pembrolizumab and RC + PLND (Arm A) will achieve superior event free survival (EFS) compared with neoadjuvant gemcitabine + cisplatin and RC + PLND (Arm B). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/19/2024
Locations: Mayo Clinic in Arizona - Phoenix ( Site 0043), Phoenix, Arizona +187 locations
Mayo Clinic in Arizona - Phoenix ( Site 0043), Phoenix, Arizona
St Joseph Heritage Healthcare-Oncology ( Site 0035), Fullerton, California
UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro, Los Angeles, California
University of California San Francisco ( Site 0010), San Francisco, California
Stanford University ( Site 0023), Stanford, California
University of Colorado, Anschutz Cancer Pavilion ( Site 0009), Aurora, Colorado
UF Health ( Site 0031), Gainesville, Florida
Indiana University Melvin and Bren Simon Cancer Center ( Site 0050), Indianapolis, Indiana
University of Iowa Hospital and Clinics ( Site 0029), Iowa City, Iowa
University of Louisville, James Graham Brown Cancer Center ( Site 0022), Louisville, Kentucky
Icahn School of Medicine at Mount Sinai ( Site 0011), New York, New York
White Plains Hospital ( Site 0039), White Plains, New York
Duke University Medical Center ( Site 0017), Durham, North Carolina
Wake Forest Baptist Health ( Site 0014), Winston-Salem, North Carolina
Oregon Health and Science University ( Site 0028), Portland, Oregon
MidLantic Urology ( Site 0002), Bala-Cynwyd, Pennsylvania
Saint Francis Cancer Center ( Site 0008), Greenville, South Carolina
The University of Tennessee Medical Center ( Site 0034), Knoxville, Tennessee
UT Southwestern Medical Center ( Site 0003), Dallas, Texas
Houston Methodist Urology Associates ( Site 0033), Houston, Texas
Urology of San Antonio ( Site 0020), San Antonio, Texas
University of Wisconsin Hospital and Clinics ( Site 0037), Madison, Wisconsin
Hospital Británico de Buenos Aires-Oncology ( Site 1551), Ciudad autónoma de Buenos Aires, Buenos Aires
Hospital Italiano de Buenos Aires ( Site 1554), ABB, Caba
Centro de Educación Médica e Investigaciones Clínicas (CEMIC) ( Site 1558), Buenos Aires, Caba
Fundacion Estudios Clinicos-Oncology ( Site 1557), Rosario, Santa Fe
Centro de Urología (CDU) ( Site 1552), Buenos Aires, Not set
Asociación de Beneficencia Hospital Sirio Libanés ( Site 1553), Buenos Aires, Not set
Macquarie University-MQ Health Clinical Trials Unit ( Site 1259), Macquarie University, New South Wales
Mater Hospital Brisbane ( Site 1257), South Brisbane, Queensland
Lyell McEwin Hospital ( Site 1252), Elizabeth Vale, South Australia
Frankston Hospital-Oncology and Haematology ( Site 1258), Frankston, Victoria
MHAT "Uni Hospital" OOD ( Site 1154), Panagyurishte, Pazardzhik
Complex Oncology Center Plovdiv ( Site 1151), Plovdiv, Not set
MHAT Central Onco Hospital OOD ( Site 1158), Plovdiv, Not set
MHAT Serdika ( Site 1152), Sofia, Not set
BC Cancer - Vancouver Center ( Site 0110), Vancouver, British Columbia
CancerCare Manitoba ( Site 0108), Winnipeg, Manitoba
Moncton Hospital ( Site 0107), Moncton, New Brunswick
Ottawa Hospital Research Institute ( Site 0109), Ottawa, Ontario
Jewish General Hospital ( Site 0106), Montreal, Quebec
SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 1406), Guangzhou, Guangdong
Sun Yat-sen Memorial Hospital, Sun Yat-sen University ( Site 1413), Guangzhou, Guangdong
Hunan Cancer Hospital ( Site 1403), Changsha, Hunan
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S, Nanjing, Jiangsu
Nantong Tumor Hospital-Urology ( Site 1405), Nantong, Jiangsu
Fudan University Shanghai Cancer Center-Urology department ( Site 1401), Shanghai, Shanghai
Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 1402), Shanghai, Shanghai
Fundación Colombiana de Cancerología Clínica Vida ( Site 1653), Medellin, Antioquia
Oncomédica S.A.S ( Site 1652), Montería, Cordoba
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 1654), Bogota, Distrito Capital De Bogota
Fundación Cardiovascular de Colombia-Santander ( Site 1657), Piedecuesta, Santander
Fundacion Valle del Lili- CIC ( Site 1656), Cali, Valle Del Cauca
Klinički bolnički centar Sestre milosrdnice ( Site 1703), Zagreb, Grad Zagreb
Klinički bolnički centar Zagreb-Klinika za onkologiju ( Site 1701), Zagreb, Grad Zagreb
Klinički bolnički centar Osijek ( Site 1705), Osijek, Osjecko-baranjska Zupanija
Klinički Bolnički Centar Split-Oncology and Radiotherapy ( Site 1702), Split, Splitsko-dalmatinska Zupanija
Fakultni nemocnice u sv. Anny v Brne ( Site 0253), Brno, Jihomoravsky Kraj
Fakultni nemocnice Hradec Kralove-Klinika onkologie a radioterapie ( Site 0254), Hradec Kralove, Not set
Fakultni Nemocnice Olomouc ( Site 0251), Olomouc, Not set
Fakultni Thomayerova nemocnice ( Site 0252), Praha 4, Not set
CHU La Timone ( Site 0456), Marseille, Bouches-du-Rhone
CHU Jean Minjoz ( Site 0453), Besancon, Doubs
CHU de Brest -Site Hopital Morvan ( Site 0461), Brest, Finistere
Institut Universitaire du Cancer Toulouse - Oncopole ( Site 0455), Toulouse, Haute-Garonne
CHU Limoges Hopital Dupuytren ( Site 0459), Limoges, Haute-Vienne
Gustave Roussy ( Site 0467), Villejuif, Ile-de-France
CHU GRENOBLE ALPES ( Site 0468), La Tronche, Isere
Centre Hospitalier Regional du Orleans ( Site 0463), Orleans, Loiret
Polyclinique du Bois ( Site 0458), Lille, Nord
Hopital Diaconesses Croix Saint Simon ( Site 0465), Paris, Not set
Universitaetsklinikum Freiburg ( Site 0512), Freiburg, Baden-Wurttemberg
Universitaetsklinik fuer Urologie ( Site 0501), Tuebingen, Baden-Wurttemberg
Caritas Krankenhaus St. Josef ( Site 0502), Regensburg, Bayern
Universitaetsklinikum Wuerzburg ( Site 0520), Wuerzburg, Bayern
Kath. Krankenhaus Marienhospital. Universitaetsklinik ( Site 0511), Herne, Nordrhein-Westfalen
Universitaetsklinikum Muenster ( Site 0516), Muenster, Nordrhein-Westfalen
Krankenhaus Martha Maria Halle-Doelau ( Site 0507), Halle, Sachsen-Anhalt
Universitaetsklinikum Carl Gustav Carus ( Site 0509), Dresden, Sachsen
Vivantes Klinikum Am Urban ( Site 0519), Berlin, Not set
UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 0305), Patras, Achaia
General Hospital of Athens "Alexandra" ( Site 0303), Athens, Attiki
Athens Medical Center ( Site 0304), Athens, Attiki
ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 0301), Chaidari, Attiki
University General Hospital of Larissa ( Site 0302), Larissa, Thessalia
Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ ( Site 1010), Szeged, Csongrad
Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház ( Site 1002), Szolnok, Jasz-Nagykun-Szolnok
Debreceni Egyetem Klinikai Kozpont ( Site 1006), Debrecen, Not set
Rambam Health Care Campus-Oncology ( Site 0751), Haifa, Not set
Hadassah Medical Center-Oncology ( Site 0757), Jerusalem, Not set
Meir Medical Center-oncology ( Site 0754), Kfar Saba, Not set
Rabin Medical Center-Oncology ( Site 0752), Petah-Tikva, Not set
Sheba Medical Center-ONCOLOGY ( Site 0753), Ramat Gan, Not set
Sourasky Medical Center-Oncology ( Site 0755), Tel Aviv, Not set
Yitzhak Shamir Medical Center-Oncology ( Site 0756), Zerifin, Not set
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 0588), Milan, Lombardia
Presidio Ospedaliero Santa Maria delle Grazie ( Site 0599), Pozzuoli, Napoli
AOU San Luigi Gonzaga di Orbassano ( Site 0595), Orbassano, Torino
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento ( Site 0598), Verona, Veneto
Azienda Ospedaliero Universitaria delle Marche-Clinica Oncologica ( Site 0593), Ancona, Not set
Ospedale Cannizzaro ( Site 0590), Catania, Not set
IRCCS Ospedale San Raffaele ( Site 0596), Milano, Not set
Istituto Oncologico Veneto IRCCS-Oncologia Medica 1 ( Site 0600), Padova, Not set
Nagoya University Hospital ( Site 1512), Nagoya, Aichi
Hirosaki University Hospital ( Site 1501), Hirosaki, Aomori
University of Tsukuba Hospital ( Site 1502), Tsukuba, Ibaraki
Kanazawa University Hospital ( Site 1509), Kanazawa, Ishikawa
Kitasato University Hospital ( Site 1506), Sagamihara, Kanagawa
Yokohama City University Medical Center ( Site 1508), Yokohama, Kanagawa
Kanagawa Cancer Center ( Site 1507), Yokohama, Kanagawa
Tohoku University Hospital ( Site 1503), Sendai, Miyagi
Hamamatsu University Hospital ( Site 1511), Hamamatsu, Shizuoka
Gifu University Hospital ( Site 1513), Gifu, Not set
Nagasaki University Hospital ( Site 1517), Nagasaki, Not set
Okayama University Hospital ( Site 1516), Okayama, Not set
Osaka International Cancer Institute ( Site 1514), Osaka, Not set
Osaka Metropolitan University Hospital ( Site 1515), Osaka, Not set
Tokyo Medical and Dental University Hospital ( Site 1505), Tokyo, Not set
Keio University Hospital ( Site 1504), Tokyo, Not set
Toyama University Hospital ( Site 1510), Toyama, Not set
Chonnam National University Hwasun Hospital ( Site 1353), Jeollanam-do, Jeonranamdo
Seoul National University Bundang Hospital ( Site 1355), Gyeonggi-do, Kyonggi-do
Asan Medical Center ( Site 1352), Songpagu, Seoul
Kyungpook National University Chilgok Hospital ( Site 1354), Daegu, Taegu-Kwangyokshi
Gachon University Gil Medical Center ( Site 1356), Incheon, Not set
Korea University Anam Hospital ( Site 1357), Seoul, Not set
Seoul National University Hospital ( Site 1351), Seoul, Not set
University Malaya Medical Centre ( Site 0352), Lembah Pantai, Kuala Lumpur
Hospital Pulau Pinang ( Site 0355), George Town, Pulau Pinang
Sarawak General Hospital ( Site 0351), Kuching, Sarawak
Sunway Medical Centre ( Site 0353), Petaling Jaya, Selangor
THE MEDICAL CITY ILOILO-The Medical City Iloilo - Clinical and Translational Research Institute-Ilo, Iloilo City, Iloilo
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu ( Site 1058), Wrocław, Dolnoslaskie
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1057), Siedlce, Mazowieckie
Narodowy Instytut Onkologii ( Site 1051), Warszawa, Mazowieckie
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1053), Przemysl, Podkarpackie
Clinical Research Center Medic-R ( Site 1061), Poznan, Wielkopolskie
Szpital Wojewodzki im. Mikolaja Kopernika ( Site 1055), Koszalin, Zachodniopomorskie
Centro Hospitalar e Universitario de Coimbra ( Site 0406), Coimbra, Not set
Inst. Portugues de Oncologia de Lisboa Francisco Gentil EPE ( Site 0409), Lisboa, Not set
CHLO, EPE - Hospital de Sao Francisco Xavier ( Site 0401), Lisboa, Not set
Hospital Geral de Santo Antonio ( Site 0408), Porto, Not set
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 1102), Cluj Napoca, Cluj
Cardiomed SRL Cluj-Napoca ( Site 1101), Cluj-Napoca, Cluj
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 1103), Cluj-Napoca, Cluj
SC Radiotherapy Center Cluj SRL ( Site 1108), Comuna Floresti, Cluj
S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1107), Craiova, Dolj
Policlinica Oncomed SRL ( Site 1106), Timisoara, Timis
SC Focus Lab Plus SRL ( Site 1104), Bucuresti, Not set
Institutul Oncologic Cluj-Oncologie Medicala ( Site 1109), Cluj, Not set
Altay Regional Oncology Dispensary ( Site 0851), Barnaul, Altayskiy Kray
National Medical Research Radiology Centre ( Site 0869), Obninsk, Kaluzskaja Oblast
National Medical Research Centre of Oncology named after N.N. Blokhin ( Site 0865), Moscow, Moskva
First Moscow State Medical University n.a. I.M.Sechenov ( Site 0871), Moscow, Moskva
Volga District Medical Center ( Site 0876), Nizhny Novgorod, Nizhegorodskaya Oblast
St.Petersburg Clinical Hospital RAS ( Site 0864), Saint Petersburg, Sankt-Peterburg
St.Petersburg State Medical Univ. n.a. acad. I.P.Pavlov ( Site 0856), Saint Petersburg, Sankt-Peterburg
Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 0852), Saint Petersburg, Sankt-Peterburg
Sverdlovsk Regional Oncology Hospital ( Site 0867), Ekaterinburg, Sverdlovskaya Oblast
Sverdlovsky Regional Clinical hospital #1 ( Site 0868), Ekaterinburg, Sverdlovskaya Oblast
Volgograd Regional Uronephrological Center ( Site 0870), Volzhsky, Volgogradskaya Oblast
Tan Tock Seng Hospital ( Site 0704), Singapore, Central Singapore
Wits Clinical Research ( Site 0603), Johannesburg, Gauteng
Steve Biko Academic Hospital ( Site 0601), Pretoria, Gauteng
Groote Schuur Hospital ( Site 0602), Cape Town, Western Cape
Hospital Universitario Central de Asturias ( Site 0654), Oviedo, Asturias
Hospital Germans Trias i Pujol. ICO de Badalona ( Site 0658), Badalona, Barcelona
Xarxa Assistencial Universitaria Manresa ( Site 0655), Manresa, Barcelona
Institut Català d'Oncologia (ICO) - Girona ( Site 0653), Girona, Gerona
CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 0660), Santiago de Compostela, La Coruna
Hospital Universitario Insular de Gran Canaria ( Site 0657), Las Palmas de Gran Canaria, Las Palmas
Fundación Instituto Valenciano de Oncología-Oncologico ( Site 0662), Valencia, Valenciana, Comunitat
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 0661), Barcelona, Not set
Hospital Clinico Universitario San Carlos de Madrid ( Site 0651), Madrid, Not set
Hospital Virgen del Rocio ( Site 0659), Sevilla, Not set
Chang Gung Memorial Hospital at Kaohsiung ( Site 1203), Kaohsiung Niao Sung Dist, Kaohsiung
China Medical University Hospital ( Site 1202), Taichung, Not set
Taipei Veterans General Hospital ( Site 1201), Taipei, Not set
I.I. Mechnykov Dnipropetrovsk Regional Clinical Hospital ( Site 0959), Dnipro, Dnipropetrovska Oblast
MI Clinical oncology dispensary of Dnipropetrovsk regional council ( Site 0954), Dnipro, Dnipropetrovska Oblast
Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval ( Site 0952), Kharkiv, Kharkivska Oblast
MNPE Regional Center of Oncology ( Site 0955), Kharkiv, Kharkivska Oblast
Municipal Non-profit Enterprise of Kharkiv Regional Council RCSDRPP ( Site 0965), Kharkiv, Kharkivska Oblast
Lviv Oncology Regional Treatment and Diagnostic Center ( Site 0960), Lviv, Lvivska Oblast
Zhytomyr Regional Oncology Center ( Site 0961), Zhytomyr, Zhytomyrska Oblast
Torbay Hospital ( Site 1804), Torquay, Devon
St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 1801), London, London, City Of
Imperial College Healthcare NHS Foundation Trust - St Mary's Hospital ( Site 1802), London, London, City Of
Conditions: Bladder Cancer
A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC
Completed
The purpose of this study is to determine whether Nivolumab, Ipilimumab combined with chemotherapy is more effective than chemotherapy by itself when treating stage IV NSCLC as the first treatment given for the disease
The purpose of this study is to determine whether Nivolumab, Ipilimumab combined with chemotherapy is more effective than chemotherapy by itself when treating stage IV NSCLC as the first treatment given for the disease Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/06/2024
Locations: Memorial Health Systems, Colorado Springs, Colorado +115 locations
Memorial Health Systems, Colorado Springs, Colorado
Local Institution - 0044, Plainville, Connecticut
Local Institution - 0045, Jacksonville, Florida
Local Institution - 0029, Marietta, Georgia
Local Institution - 0091, Wichita, Kansas
Local Institution - 0004, Lexington, Kentucky
Local Institution - 0105, Detroit, Michigan
Local Institution - 0058, Johnson City, New York
Local Institution - 0098, Mineola, New York
Local Institution - 0095, Columbus, Ohio
Local Institution - 0006, Lancaster, Pennsylvania
Local Institution - 0047, Pittsburgh, Pennsylvania
Local Institution - 0093, Pittsburgh, Pennsylvania
Local Institution - 0094, Charleston, South Carolina
Southwest Regional Cancer Clinic, Saint George, Utah
Local Institution - 0099, Madison, Wisconsin
Local Institution - 0014, Ciudad Autónoma de Buenos Aires, Buenos Aires
Local Institution - 0028, Rio Cuarto, Cordoba
Local Institution - 0026, Viedma, Rio Negro
Local Institution - 0027, Rosario, Santa Fe
Local Institution - 0030, Cordoba, Not set
Local Institution - 0086, Gosford, New South Wales
Local Institution - 0040, Bedford Park, South Australia
Local Institution - 0089, Box Hill, Victoria
Local Institution - 0036, Heidelberg, Victoria
Local Institution - 0078, Murdoch, Western Australia
Local Institution - 0002, Gilly, Not set
Local Institution - 0033, Leuven, Not set
Local Institution - 0001, Roeselare, Not set
Local Institution - 0068, Natal, RIO Grande DO Norte
Local Institution - 0063, Ijui, Rio Grande Do Sul
Local Institution - 0067, Porto Alegre, Rio Grande Do Sul
Local Institution - 0069, Blumenau, Santa Catarina
Local Institution - 0064, Barretos, Sao Paulo
Local Institution - 0065, Sao Jose Do Rio Preto, Sao Paulo
Local Institution - 0066, Rio De Janeiro, Not set
Local Institution - 0070, São Paulo, Not set
Local Institution - 0090, Montreal, Quebec
Local Institution - 0083, Montreal, Quebec
Local Institution - 0082, Montreal, Quebec
Local Institution - 0080, Rimouski, Quebec
Local Institution - 0084, Santiago, Metropolitana
Local Institution - 0059, Santiago, Región Metropolitana De Santiago
Local Institution - 0079, Vina Del Mar, Valparaiso
Local Institution - 0139, Beijing, BEI
Local Institution - 0146, Haikou, Hainan
Local Institution - 0148, Zhengzhou, Henan
Local Institution - 0120, Zhengzhou, Henan
Local Institution - 0144, Changsha, Hunan
Local Institution - 0106, Changchun, Jilin
Local Institution - 0108, Xi'an City, Shan3xi
Local Institution - 0110, Hangzhou, Zhejiang
Local Institution - 0111, Zhejiang, Zhejiang
Local Institution - 0113, Beijing, Not set
Local Institution - 0112, Shanghai, Not set
Local Institution - 0010, Bron, Rhone Alpes
Local Institution - 0009, Lyon Cedex08, Rhône-Alpes
Local Institution - 0013, Caen, Not set
Local Institution - 0071, Lille Cedex, Not set
Local Institution - 0012, Montpellier, Not set
Local Institution - 0035, Nantes, Not set
Local Institution - 0011, Paris Cedex 20, Not set
Local Institution - 0097, Saint-Brieuc, Not set
Local Institution - 0073, Berlin, Not set
Local Institution - 0016, Gauting, Not set
Local Institution - 0072, Grosshansdorf, Not set
Local Institution - 0019, Hemer, Not set
Local Institution - 0017, Immenhausen, Not set
Local Institution - 0074, Magdeburg, Not set
Local Institution - 0015, Muenchen, Not set
Local Institution - 0018, Stuttgart, Not set
Local Institution - 0021, Dublin, Not set
Local Institution - 0020, Limerick, Not set
Local Institution - 0042, Lucca, Not set
Local Institution - 0041, Milano, Not set
Local Institution - 0043, Napoli, Not set
Local Institution - 0101, Fukushima-shi, Fukushima
Local Institution - 0118, Maebashi-shi, Gunma
Local Institution - 0128, Ota-shi, Gunma
Local Institution - 0138, Hiroshima-shi, Hiroshima
Local Institution - 0137, Hiroshima-shi, Hiroshima
Local Institution - 0127, Sapporo-shi, Hokkaido
Local Institution - 0131, Akashi-shi, Hyogo
Local Institution - 0119, Himeji-shi, Hyogo
Local Institution - 0104, Kobe-shi, Hyogo
Local Institution - 0115, Kanazawa-shi, Ishikawa
Local Institution - 0100, Shiwa-gun, Iwate
Local Institution - 0129, Yokohama-shi, Kanagawa
Local Institution - 0114, Yokohama-Shi, Kanagawa
Local Institution - 0134, Yokohama-shi, Kanagawa
Local Institution - 0116, Niigata-shi, Niigata
Local Institution - 0136, Okayama-shi, Okayama
Local Institution - 0135, Habikino-shi, Osaka
Local Institution - 0103, Osaka-Sayama, Osaka
Local Institution - 0102, Kitaadachi-gun, Saitama
Local Institution - 0132, Ube-shi, Yamaguchi
Local Institution - 0130, Osaka, Not set
Local Institution - 0077, La Paz, BAJA Californa SUR
Local Institution - 0061, Guadalajara, Jalisco
Local Institution - 0075, Veracruz, Veracruz, Not set
Local Institution - 0087, Bydgoszcz, Not set
Local Institution - 0022, Bytom, Not set
Local Institution - 0085, Gdańsk, Not set
Local Institution - 0034, Bucharest, Not set
Local Institution - 0031, Cluj Napoca, Not set
Local Institution - 0032, Craiova, Not set
Local Institution - 0024, Moscow, Not set
Local Institution - 0025, St.petersburg, Not set
Local Institution - 0054, A Coruña, Not set
Local Institution - 0053, Barcelona, Not set
Local Institution - 0052, Madrid, Not set
Local Institution - 0055, Malaga, Not set
Local Institution - 0056, Valencia, Not set
Local Institution - 0050, Guildford, Not set
Local Institution - 0049, London, Not set
Local Institution - 0048, Tauton, Not set
Conditions: Non-Small Cell Lung Cancer
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Completed
Pembrolizumab is a new type of drug for mesothelioma (immunotherapy). Laboratory tests show that this drug works by helping improve the body's immune response to help fight cancer. Pembrolizumab may help the immune system to recognize cancer cells and slow down the growth and/or spreading of cancer.
Pembrolizumab is a new type of drug for mesothelioma (immunotherapy). Laboratory tests show that this drug works by helping improve the body's immune response to help fight cancer. Pembrolizumab may help the immune system to recognize cancer cells and slow down the growth and/or spreading of cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/05/2024
Locations: Tom Baker Cancer Centre, Calgary, Alberta +56 locations
Tom Baker Cancer Centre, Calgary, Alberta
Cross Cancer Institute, Edmonton, Alberta
BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia
BCCA - Fraser Valley Cancer Centre, Surrey, British Columbia
CancerCare Manitoba, Winnipeg, Manitoba
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario
London Regional Cancer Program, London, Ontario
Ottawa Hospital Research Institute, Ottawa, Ontario
University Health Network, Toronto, Ontario
CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec
The Research Institute of the McGill University, Montreal, Quebec
University Institute of Cardiology and, Quebec City, Quebec
Allan Blair Cancer Centre, Regina, Saskatchewan
AP-HP Hopital Tenon, Paris, Cedex 20
Centre Alexis Vautrin, Vandoeuvre les Nancy, Cedex
CHU Dupuytren, Limoges, FR
Hopital du Scorff, Lorient, FR
Lyon URCOT, Pierre-benite, FR
CHU Rennes - Hopital Pontchaillou, Rennes, FR
Institut Gustave-Roussy, Villejuif, FR
CHRU de Tours - Hopital Bretonneau, Tours Cedex, Tours Cedex 9
CHU - Angers, Angers, Not set
Hopital Jean Minjoz, Besancon Cedex, Not set
Institut Bergonie, Bordeaux, Not set
Boulogne - Ambroise Pare, Boulogne, Not set
Caen - CHU, Caen, Not set
Clermont-Ferrand - CHU, Clermont-Ferrand, Not set
Centre Hospitalier Intercommunal de Creteil, Creteil, Not set
Centre Hospitalier du Mans, Le Mans, Not set
Lille - Hopital Calmette, Lille, Not set
Marseille - Hopital Nord, Marseille, Not set
Not set, Montpellier 34298, Not set
Centre Hospitalier de Mulhouse, Mulhouse, Not set
Centre Rene Gauducheau, Nantes, Not set
Hopital Bichat, Paris, Not set
Nouvel Hopital Civil Hopitaux, Strasbourg, Not set
CHITS Toulon Sainte Musse, Toulon, Not set
Hopital Larrey, Toulouse, Not set
Oncologia SS Antonio e Biagio Alessandria, Alessandria, AL
Azienda Ospedaliera San Giuseppe Moscati, Avellino, AV
IRCCS Ospedale Oncologico Giovanni Paolo II, Bari, BA
Oncologia Medica Humanitas Gavazzeni Bergamo, Bergamo, BG
Azienda Ospedaliera Garibaldi Nesima, Catania, CT
Instituto Clinico Humanitas, Rozzano (MI), Lombardia
Oncologia Medica IRCCS Arcispedale Maria, Reggio Emilia, RE
Istituti Fisioterapici Ospitalieri IFO Istituto, Rome, RM
PO A Perrino ASL Brindisi - UOC Oncologia Medica, Brindisi, Not set
AOU Policlinico Vittorio Emanuele UOC di Oncologia, Catania, Not set
U.O. di Oncologia Ospedale Villa Scassi, Genova, Not set
Intstituto Scientifico Romangnolo, Meldola, Not set
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Not set
U.O.C. di Oncologia U.L.S.S. 13, Mirano, Not set
Azienda Ospedaliera di Rilievo Nazionale, Napoli, Not set
Dott. Fortunato Ciardiello,Cattedra Oncologia Medica, Napoli, Not set
U.O.S.D. Day Hospital Oncologico-Pneumologico, Napoli, Not set
Unita Sperimentazioni Cliniche Istituto per lo, Napoli, Not set
Azienda USL di Piacenza, Ospedale Gugliemimo Salieto, Piacenza, Not set
Conditions: Mesothelioma
Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors
Completed
This first-in-human open-label, multicenter, dose-escalation and expansion study is designed to evaluate the safety, tolerability, and PK of tiragolumab alone or in combination with atezolizumab and/or other anti-cancer therapies in participants with locally advanced, recurrent, or metastatic incurable tumors for whom standard therapy does not exist, has proven to be ineffective or intolerable, or is considered inappropriate, or for whom a clinical trial of an investigational agent is a recogniz... Read More
This first-in-human open-label, multicenter, dose-escalation and expansion study is designed to evaluate the safety, tolerability, and PK of tiragolumab alone or in combination with atezolizumab and/or other anti-cancer therapies in participants with locally advanced, recurrent, or metastatic incurable tumors for whom standard therapy does not exist, has proven to be ineffective or intolerable, or is considered inappropriate, or for whom a clinical trial of an investigational agent is a recognized standard of care. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/04/2024
Locations: Honor Health Research Institute, Scottsdale, Arizona +27 locations
Honor Health Research Institute, Scottsdale, Arizona
University of California Los Angeles, Santa Monica, California
Yale Cancer Center, New Haven, Connecticut
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Dana Farber Cancer Institute, Boston, Massachusetts
Henry Ford Hospital, Detroit, Michigan
Memorial Sloan-Kettering Cancer Center, New York, New York
Tennessee Oncology - Nashville, Nashville, Tennessee
Kinghorn Cancer Centre; St Vincents Hospital, Darlinghurst, New South Wales
Peter MacCallum Cancer Center, North Melbourne, Victoria
Princess Margaret Hospital, Toronto, Ontario
Institut Bergonie CLCC Bordeaux, Bordeaux, Not set
Centre Léon Bérard Centre Régional de Lutte Contre Le Cancer Rhône Alpes, Lyon, Not set
Institut Curie, Paris, Not set
Institut Claudius Regaud; Departement Oncologie Medicale, Toulouse, Not set
Institut Gustave Roussy, Villejuif, Not set
National Cancer Center Hospital, Tokyo, Not set
The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Tokyo, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
ICO L'Hospitalet; Servicio de oncologia medica, L'Hospitalet de Llobregat, Barcelona
Hospital Univ Vall d'Hebron; Servicio de Oncologia, Sant Andreu de La Barca, Barcelona
Clinica Universitaria de Navarra; Servicio de oncología, Pamplona, Navarra
Hospital del Mar, Barcelona, Not set
Hospital Universitario HM Sanchinarro-CIOCC; Oncología Médica, Madrid, Not set
Hospital Clinico Universitario de Valencia, Valencia, Not set
Conditions: Advanced/Metastatic Tumors
Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features
Recruiting
The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. Eligible patients will be assigned to one of the four RAINBO trials based on the molecular profile of their cancer:
* p53 abnormal endometrial cancer patients to the p53abn-RED trial
* mismatch repair deficient endometrial cancer patients to the MMRd-GREEN trial
* no specific molecular profile endometrial cancer patients to NSMP-ORANGE trial
* POLE mutant endometrial... Read More
The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. Eligible patients will be assigned to one of the four RAINBO trials based on the molecular profile of their cancer:
* p53 abnormal endometrial cancer patients to the p53abn-RED trial
* mismatch repair deficient endometrial cancer patients to the MMRd-GREEN trial
* no specific molecular profile endometrial cancer patients to NSMP-ORANGE trial
* POLE mutant endometrial cancer patients to the POLEmut-BLUE trial Read Less
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
11/26/2024
Locations: The POLEmut-BLUE trial: Princess Margaret Cancer Centre, University of Toronto, Toronto, Not set +13 locations
The POLEmut-BLUE trial: Princess Margaret Cancer Centre, University of Toronto, Toronto, Not set
The POLEmut-BLUE trial: University of British Columbia, Vancouver, Not set
The p53abn-RED trial: Institute Gustave Roussy, Villejuif, Not set
Amsterdam University Medical Center, Amsterdam, Not set
Amphia Ziekenhuis, Breda, Not set
Instituut Verbeeten, Breda, Not set
Haags Medisch Centrum, Den Haag, Not set
Catharina Ziekenhuis, Eindhoven, Not set
Medisch Spectrum Twente, Enschede, Not set
Universitair Medisch Centrum Groningen, Groningen, Not set
The MMRd-GREEN trial: Leiden University Medical Center, Leiden, Not set
Erasmus Medical Center, Rotterdam, Not set
The NSMP-ORANGE trial: Barts Health NHS Trust, London, Not set
The NSMP-ORANGE trial: Manchester Academic Health Science Centre, St Mary's Hospita, Manchester, Not set
Conditions: Endometrial Cancer
A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
Active Not Recruiting
The primary purpose of this study is to characterize the safety profile of BMS-986408 as monotherapy and in combination with nivolumab or nivolumab and ipilimumab to establish the maximum tolerated dose (MTD). The Recommended Phase 2 Dose (RP2D) that optimizes the pharmacokinetic/pharmacodynamic (PK/PD) relationship of BMS-986408 will also be determined.
The primary purpose of this study is to characterize the safety profile of BMS-986408 as monotherapy and in combination with nivolumab or nivolumab and ipilimumab to establish the maximum tolerated dose (MTD). The Recommended Phase 2 Dose (RP2D) that optimizes the pharmacokinetic/pharmacodynamic (PK/PD) relationship of BMS-986408 will also be determined. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/20/2024
Locations: Local Institution - 0010, Boston, Massachusetts +17 locations
Local Institution - 0010, Boston, Massachusetts
Local Institution - 0001, Hackensack, New Jersey
Local Institution - 0003, Houston, Texas
Local Institution - 0007, Edmonton, Alberta
Local Institution - 0011, Hamilton, Ontario
Local Institution - 0005, Ottawa, Ontario
Local Institution - 0006, Toronto, Ontario
Local Institution - 0015, Bordeaux, Aquitaine
Local Institution - 0014, Villejuif, Paris
Local Institution - 0018, Marseille, Not set
Local Institution - 0019, Toulouse, Not set
Local Institution - 0024, Málaga, Andalucía
Local Institution - 0025, Madrid, Madrid, Comunidad De
Local Institution - 0022, Madrid, Not set
Local Institution - 0023, Madrid, Not set
Local Institution - 0021, st.Gallen, Sankt Gallen
Local Institution - 0012, Basel, Not set
Local Institution - 0020, Geneva, Not set
Conditions: Advanced Solid Tumors
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer
Terminated
This phase III trial compares the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus standard chemotherapy alone in treating patients with nasopharyngeal cancer that has come back (recurrent) or spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs,... Read More
This phase III trial compares the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus standard chemotherapy alone in treating patients with nasopharyngeal cancer that has come back (recurrent) or spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, carboplatin, and gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving nivolumab with the usual chemotherapy may work better than the standard chemotherapy alone in treating patients with nasopharyngeal cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/20/2024
Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama +324 locations
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Anchorage Associates in Radiation Medicine, Anchorage, Alaska
Anchorage Radiation Therapy Center, Anchorage, Alaska
Alaska Breast Care and Surgery LLC, Anchorage, Alaska
Alaska Oncology and Hematology LLC, Anchorage, Alaska
Alaska Women's Cancer Care, Anchorage, Alaska
Anchorage Oncology Centre, Anchorage, Alaska
Katmai Oncology Group, Anchorage, Alaska
Providence Alaska Medical Center, Anchorage, Alaska
Cancer Center at Saint Joseph's, Phoenix, Arizona
Mercy Hospital Fort Smith, Fort Smith, Arkansas
CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas
Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California
Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California
Epic Care-Dublin, Dublin, California
Bay Area Breast Surgeons Inc, Emeryville, California
Epic Care Partners in Cancer Care, Emeryville, California
Contra Costa Regional Medical Center, Martinez, California
Alta Bates Summit Medical Center - Summit Campus, Oakland, California
Bay Area Tumor Institute, Oakland, California
Stanford Cancer Institute Palo Alto, Palo Alto, California
Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California
Mission Hope Medical Oncology - Santa Maria, Santa Maria, California
Epic Care Cyberknife Center, Walnut Creek, California
Penrose-Saint Francis Healthcare, Colorado Springs, Colorado
Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado
Porter Adventist Hospital, Denver, Colorado
Mercy Medical Center, Durango, Colorado
Southwest Oncology PC, Durango, Colorado
Saint Anthony Hospital, Lakewood, Colorado
Littleton Adventist Hospital, Littleton, Colorado
Longmont United Hospital, Longmont, Colorado
Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado
Parker Adventist Hospital, Parker, Colorado
Saint Mary Corwin Medical Center, Pueblo, Colorado
Holy Cross Hospital, Fort Lauderdale, Florida
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida
Mayo Clinic in Florida, Jacksonville, Florida
Memorial Hospital West, Pembroke Pines, Florida
Hawaii Cancer Care - Westridge, 'Aiea, Hawaii
Pali Momi Medical Center, 'Aiea, Hawaii
Queen's Cancer Center - Pearlridge, 'Aiea, Hawaii
The Cancer Center of Hawaii-Pali Momi, 'Aiea, Hawaii
Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii
Queen's Cancer Cenrer - POB I, Honolulu, Hawaii
Queen's Medical Center, Honolulu, Hawaii
Straub Clinic and Hospital, Honolulu, Hawaii
University of Hawaii Cancer Center, Honolulu, Hawaii
Kuakini Medical Center, Honolulu, Hawaii
Queen's Cancer Center - Kuakini, Honolulu, Hawaii
The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii
Kapiolani Medical Center for Women and Children, Honolulu, Hawaii
Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii
Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho
Saint Luke's Cancer Institute - Boise, Boise, Idaho
Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho
Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho
Walter Knox Memorial Hospital, Emmett, Idaho
Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho
Idaho Urologic Institute-Meridian, Meridian, Idaho
Saint Luke's Cancer Institute - Meridian, Meridian, Idaho
Saint Luke's Cancer Institute - Nampa, Nampa, Idaho
Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho
Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho
Kootenai Cancer Clinic, Sandpoint, Idaho
Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho
Saint Anthony's Health, Alton, Illinois
Rush - Copley Medical Center, Aurora, Illinois
Illinois CancerCare-Bloomington, Bloomington, Illinois
Illinois CancerCare-Canton, Canton, Illinois
Memorial Hospital of Carbondale, Carbondale, Illinois
SIH Cancer Institute, Carterville, Illinois
Illinois CancerCare-Carthage, Carthage, Illinois
Centralia Oncology Clinic, Centralia, Illinois
Carle at The Riverfront, Danville, Illinois
Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois
Decatur Memorial Hospital, Decatur, Illinois
Illinois CancerCare-Dixon, Dixon, Illinois
Carle Physician Group-Effingham, Effingham, Illinois
Crossroads Cancer Center, Effingham, Illinois
Illinois CancerCare-Eureka, Eureka, Illinois
Illinois CancerCare-Galesburg, Galesburg, Illinois
Western Illinois Cancer Treatment Center, Galesburg, Illinois
Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois
Illinois CancerCare-Macomb, Macomb, Illinois
Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois
Good Samaritan Regional Health Center, Mount Vernon, Illinois
Cancer Care Center of O'Fallon, O'Fallon, Illinois
Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois
Illinois CancerCare-Pekin, Pekin, Illinois
Illinois CancerCare-Peoria, Peoria, Illinois
Methodist Medical Center of Illinois, Peoria, Illinois
Illinois CancerCare-Peru, Peru, Illinois
Valley Radiation Oncology, Peru, Illinois
Illinois CancerCare-Princeton, Princeton, Illinois
Southern Illinois University School of Medicine, Springfield, Illinois
Springfield Clinic, Springfield, Illinois
Memorial Medical Center, Springfield, Illinois
Carle Cancer Center, Urbana, Illinois
The Carle Foundation Hospital, Urbana, Illinois
Rush-Copley Healthcare Center, Yorkville, Illinois
Reid Health, Richmond, Indiana
Mary Greeley Medical Center, Ames, Iowa
McFarland Clinic - Ames, Ames, Iowa
McFarland Clinic - Boone, Boone, Iowa
Saint Anthony Regional Hospital, Carroll, Iowa
Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa
Mercy Cancer Center-West Lakes, Clive, Iowa
Alegent Health Mercy Hospital, Council Bluffs, Iowa
Greater Regional Medical Center, Creston, Iowa
Iowa Methodist Medical Center, Des Moines, Iowa
Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa
Broadlawns Medical Center, Des Moines, Iowa
Mercy Medical Center - Des Moines, Des Moines, Iowa
Mission Cancer and Blood - Laurel, Des Moines, Iowa
Iowa Lutheran Hospital, Des Moines, Iowa
McFarland Clinic - Trinity Cancer Center, Fort Dodge, Iowa
Trinity Regional Medical Center, Fort Dodge, Iowa
McFarland Clinic - Jefferson, Jefferson, Iowa
McFarland Clinic - Marshalltown, Marshalltown, Iowa
Methodist West Hospital, West Des Moines, Iowa
Mercy Medical Center-West Lakes, West Des Moines, Iowa
Central Care Cancer Center - Garden City, Garden City, Kansas
Central Care Cancer Center - Great Bend, Great Bend, Kansas
Flaget Memorial Hospital, Bardstown, Kentucky
Commonwealth Cancer Center-Corbin, Corbin, Kentucky
Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky
Saint Joseph Hospital East, Lexington, Kentucky
Saint Joseph London, London, Kentucky
Jewish Hospital, Louisville, Kentucky
Saints Mary and Elizabeth Hospital, Louisville, Kentucky
UofL Health Medical Center Northeast, Louisville, Kentucky
Jewish Hospital Medical Center South, Shepherdsville, Kentucky
LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana
Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana
Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana
Our Lady of the Lake Physicians Group - Medical Oncology, Baton Rouge, Louisiana
Saint Joseph Mercy Hospital, Ann Arbor, Michigan
Saint Joseph Mercy Brighton, Brighton, Michigan
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan
Saint Joseph Mercy Canton, Canton, Michigan
Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan
Caro Cancer Center, Caro, Michigan
Saint Joseph Mercy Chelsea, Chelsea, Michigan
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan
Hematology Oncology Consultants-Clarkston, Clarkston, Michigan
Newland Medical Associates-Clarkston, Clarkston, Michigan
Ascension Saint John Hospital, Detroit, Michigan
Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan
Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan
Genesee Hematology Oncology PC, Flint, Michigan
Genesys Hurley Cancer Institute, Flint, Michigan
Hurley Medical Center, Flint, Michigan
Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan
Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan
Sparrow Hospital, Lansing, Michigan
Hope Cancer Clinic, Livonia, Michigan
Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan
Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan
Michigan Breast Specialists-Macomb Township, Macomb, Michigan
Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan
21st Century Oncology-Pontiac, Pontiac, Michigan
Hope Cancer Center, Pontiac, Michigan
Newland Medical Associates-Pontiac, Pontiac, Michigan
Saint Joseph Mercy Oakland, Pontiac, Michigan
Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan
Ascension Saint Mary's Hospital, Saginaw, Michigan
Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan
Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan
Ascension Saint Joseph Hospital, Tawas City, Michigan
Advanced Breast Care Center PLLC, Warren, Michigan
Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan
Macomb Hematology Oncology PC, Warren, Michigan
Michigan Breast Specialists-Warren, Warren, Michigan
Saint John Macomb-Oakland Hospital, Warren, Michigan
Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan
Huron Gastroenterology PC, Ypsilanti, Michigan
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan
Sanford Joe Lueken Cancer Center, Bemidji, Minnesota
Mayo Clinic in Rochester, Rochester, Minnesota
Sanford Thief River Falls Medical Center, Thief River Falls, Minnesota
Sanford Cancer Center Worthington, Worthington, Minnesota
Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri
Central Care Cancer Center - Bolivar, Bolivar, Missouri
Saint Francis Medical Center, Cape Girardeau, Missouri
Southeast Cancer Center, Cape Girardeau, Missouri
Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri
Parkland Health Center - Farmington, Farmington, Missouri
Capital Region Southwest Campus, Jefferson City, Missouri
Freeman Health System, Joplin, Missouri
Mercy Hospital Joplin, Joplin, Missouri
Delbert Day Cancer Institute at PCRMC, Rolla, Missouri
Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri
Heartland Regional Medical Center, Saint Joseph, Missouri
Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri
Washington University School of Medicine, Saint Louis, Missouri
Mercy Hospital South, Saint Louis, Missouri
Siteman Cancer Center-South County, Saint Louis, Missouri
Missouri Baptist Medical Center, Saint Louis, Missouri
Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri
Mercy Hospital Saint Louis, Saint Louis, Missouri
Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri
Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri
Mercy Hospital Springfield, Springfield, Missouri
CoxHealth South Hospital, Springfield, Missouri
Missouri Baptist Sullivan Hospital, Sullivan, Missouri
Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri
Mercy Hospital Washington, Washington, Missouri
Community Hospital of Anaconda, Anaconda, Montana
Billings Clinic Cancer Center, Billings, Montana
Bozeman Deaconess Hospital, Bozeman, Montana
Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana
Great Falls Clinic, Great Falls, Montana
Kalispell Regional Medical Center, Kalispell, Montana
Saint Patrick Hospital - Community Hospital, Missoula, Montana
Community Medical Hospital, Missoula, Montana
CHI Health Saint Francis, Grand Island, Nebraska
CHI Health Good Samaritan, Kearney, Nebraska
Saint Elizabeth Regional Medical Center, Lincoln, Nebraska
Nebraska Methodist Hospital, Omaha, Nebraska
Alegent Health Immanuel Medical Center, Omaha, Nebraska
Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska
Alegent Health Lakeside Hospital, Omaha, Nebraska
Creighton University Medical Center, Omaha, Nebraska
Midlands Community Hospital, Papillion, Nebraska
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
Memorial Sloan Kettering Monmouth, Middletown, New Jersey
Memorial Sloan Kettering Bergen, Montvale, New Jersey
Memorial Sloan Kettering Commack, Commack, New York
Memorial Sloan Kettering Westchester, Harrison, New York
Memorial Sloan Kettering Cancer Center, New York, New York
Memorial Sloan Kettering Nassau, Uniondale, New York
Sanford Bismarck Medical Center, Bismarck, North Dakota
Sanford South University Medical Center, Fargo, North Dakota
Southpointe-Sanford Medical Center Fargo, Fargo, North Dakota
Sanford Medical Center Fargo, Fargo, North Dakota
Sanford Broadway Medical Center, Fargo, North Dakota
Sanford Roger Maris Cancer Center, Fargo, North Dakota
Indu and Raj Soin Medical Center, Beavercreek, Ohio
Saint Elizabeth Boardman Hospital, Boardman, Ohio
Dayton Physicians LLC-Miami Valley South, Centerville, Ohio
Miami Valley Hospital South, Centerville, Ohio
University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio
Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio
Oncology Hematology Care Inc-Kenwood, Cincinnati, Ohio
Bethesda North Hospital, Cincinnati, Ohio
TriHealth Cancer Institute-Westside, Cincinnati, Ohio
TriHealth Cancer Institute-Anderson, Cincinnati, Ohio
Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Miami Valley Hospital, Dayton, Ohio
Dayton Physician LLC-Miami Valley Hospital North, Dayton, Ohio
Miami Valley Hospital North, Dayton, Ohio
Armes Family Cancer Center, Findlay, Ohio
Blanchard Valley Hospital, Findlay, Ohio
Orion Cancer Care, Findlay, Ohio
Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio
Dayton Physicians LLC-Atrium, Franklin, Ohio
Dayton Physicians LLC-Wayne, Greenville, Ohio
Wayne Hospital, Greenville, Ohio
Greater Dayton Cancer Center, Kettering, Ohio
Kettering Medical Center, Kettering, Ohio
Springfield Regional Cancer Center, Springfield, Ohio
Springfield Regional Medical Center, Springfield, Ohio
Dayton Physicians LLC - Troy, Troy, Ohio
Upper Valley Medical Center, Troy, Ohio
Saint Joseph Warren Hospital, Warren, Ohio
University of Cincinnati Cancer Center-West Chester, West Chester, Ohio
Saint Elizabeth Youngstown Hospital, Youngstown, Ohio
Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma
Saint Alphonsus Medical Center-Baker City, Baker City, Oregon
Saint Charles Health System, Bend, Oregon
Clackamas Radiation Oncology Center, Clackamas, Oregon
Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon
Bay Area Hospital, Coos Bay, Oregon
Providence Newberg Medical Center, Newberg, Oregon
Saint Alphonsus Medical Center-Ontario, Ontario, Oregon
Providence Portland Medical Center, Portland, Oregon
Providence Saint Vincent Medical Center, Portland, Oregon
Saint Charles Health System-Redmond, Redmond, Oregon
Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania
Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania
Pocono Medical Center, East Stroudsburg, Pennsylvania
Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania
Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota
Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota
Saint Joseph Regional Cancer Center, Bryan, Texas
VCU Massey Cancer Center at Stony Point, Richmond, Virginia
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia
Providence Regional Cancer System-Aberdeen, Aberdeen, Washington
PeaceHealth Saint Joseph Medical Center, Bellingham, Washington
Harrison HealthPartners Hematology and Oncology-Bremerton, Bremerton, Washington
Harrison Medical Center, Bremerton, Washington
Highline Medical Center-Main Campus, Burien, Washington
Providence Regional Cancer System-Centralia, Centralia, Washington
Swedish Cancer Institute-Edmonds, Edmonds, Washington
Saint Elizabeth Hospital, Enumclaw, Washington
Providence Regional Cancer Partnership, Everett, Washington
Saint Francis Hospital, Federal Way, Washington
Swedish Cancer Institute-Issaquah, Issaquah, Washington
Kadlec Clinic Hematology and Oncology, Kennewick, Washington
Providence Regional Cancer System-Lacey, Lacey, Washington
Saint Clare Hospital, Lakewood, Washington
PeaceHealth Saint John Medical Center, Longview, Washington
Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo, Washington
Pacific Gynecology Specialists, Seattle, Washington
Swedish Medical Center-Ballard Campus, Seattle, Washington
Swedish Medical Center-Cherry Hill, Seattle, Washington
Swedish Medical Center-First Hill, Seattle, Washington
PeaceHealth United General Medical Center, Sedro-Woolley, Washington
Providence Regional Cancer System-Shelton, Shelton, Washington
Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington
Northwest Medical Specialties PLLC, Tacoma, Washington
PeaceHealth Southwest Medical Center, Vancouver, Washington
Providence Saint Mary Regional Cancer Center, Walla Walla, Washington
Providence Regional Cancer System-Yelm, Yelm, Washington
Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin
Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin
Billings Clinic-Cody, Cody, Wyoming
Welch Cancer Center, Sheridan, Wyoming
University Health Network-Princess Margaret Hospital, Toronto, Ontario
Chinese University of Hong Kong-Prince of Wales Hospital, Shatin, Hong Kong
National Cancer Centre Singapore, Singapore, Not set
Conditions: Metastatic Nasopharyngeal Carcinoma, Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Metastatic Nasopharyngeal Undifferentiated Carcinoma, Nasopharyngeal Nonkeratinizing Carcinoma, Recurrent Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Recurrent Nasopharyngeal Undifferentiated Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8, Stage IVA Nasopharyngeal Carcinoma AJCC v8, Stage IVB Nasopharyngeal Carcinoma AJCC v8, Metastatic Nasopharyngeal Nonkeratinizing Carcinoma
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)
Active Not Recruiting
The purpose of this study is to assess the safety and efficacy of treatment with pembrolizumab (MK-3475) compared to a combination of carboplatin and paclitaxel in women with mismatch repair deficient (dMMR) advanced or recurrent endometrial carcinoma who have not previously been treated with prior systemic chemotherapy.
The primary study hypotheses are that pembrolizumab is superior to the combination of carboplatin and paclitaxel with respect to Progression Free Survival (PFS) per Response Ev... Read More
The purpose of this study is to assess the safety and efficacy of treatment with pembrolizumab (MK-3475) compared to a combination of carboplatin and paclitaxel in women with mismatch repair deficient (dMMR) advanced or recurrent endometrial carcinoma who have not previously been treated with prior systemic chemotherapy.
The primary study hypotheses are that pembrolizumab is superior to the combination of carboplatin and paclitaxel with respect to Progression Free Survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed by Blinded Independent Central Review (BICR) and Overall Survival (OS). Read Less
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
11/19/2024
Locations: HonorHealth-USOR HonorHealth ( Site 8000), Phoenix, Arizona +194 locations
HonorHealth-USOR HonorHealth ( Site 8000), Phoenix, Arizona
Moores Cancer Center ( Site 0037), La Jolla, California
Kaiser Permanente Riverside Medical Center ( Site 0045), Riverside, California
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0013), New Haven, Connecticut
Mount Sinai Cancer Center ( Site 0018), Miami Beach, Florida
Sarasota Memorial Hospital ( Site 0005), Sarasota, Florida
Northside Hospital ( Site 0017), Atlanta, Georgia
Southeastern Regional Medical Center ( Site 0046), Newnan, Georgia
Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003), Zion, Illinois
St. Vincent Hospital and Health Care Center, Inc ( Site 0006), Indianapolis, Indiana
Baptist Health Lexington ( Site 0042), Lexington, Kentucky
Maryland Oncology Hematology, P.A.-USOR Maryland Oncology Hematology, P.A. ( Site 8002), Rockville, Maryland
University of Massachusetts Medical School-Division of Gynecologic Oncology ( Site 0008), Worcester, Massachusetts
Karmanos Cancer Institute ( Site 0029), Detroit, Michigan
St. Dominic's Hospital ( Site 0024), Jackson, Mississippi
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0026), Hackensack, New Jersey
The Blavatnik Family- Chelsea Medical Center at Mount Sinai ( Site 0023), New York, New York
Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0016), New York, New York
Icahn School of Medicine at Mount Sinai ( Site 0052), New York, New York
Memorial Sloan Kettering Cancer Center ( Site 0009), New York, New York
FirstHealth Clinical Trials ( Site 0050), Pinehurst, North Carolina
Sanford Medical Center ( Site 0054), Bismarck, North Dakota
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0055), Fargo, North Dakota
University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0039), Cincinnati, Ohio
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus, Ohio
Providence Portland Medical Center ( Site 0031), Portland, Oregon
Sidney Kimmel Cancer Center - Jefferson Health ( Site 0053), Philadelphia, Pennsylvania
University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0034), Pittsburgh, Pennsylvania
AHN West Penn Hospital ( Site 0011), Pittsburgh, Pennsylvania
Asplundh Cancer Pavilion ( Site 0014), Willow Grove, Pennsylvania
Sanford Cancer Center-Gynecologic Oncology ( Site 0002), Sioux Falls, South Dakota
Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003), Austin, Texas
Texas Oncology - Dallas-USOR Texas Oncology - Dallas (Sammons) ( Site 8005), Dallas, Texas
Texas Oncology - Tyler-USOR Texas Oncology - Northeast Texas ( Site 8004), Tyler, Texas
VCU Health Adult Outpatient Pavillion ( Site 0022), Richmond, Virginia
Northern Cancer Institute ( Site 0206), St Leonards, New South Wales
Westmead Hospital-Department of Gynaecological Oncology ( Site 0201), Westmead, New South Wales
Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si, Brisbane, Queensland
Monash Health ( Site 0202), Clayton, Victoria
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0207), Melbourne, Victoria
Epworth Freemasons ( Site 0203), Melbourne, Victoria
St. John of God Subiaco Hospital-Oncology Clinical Trials Unit ( Site 0204), Subiaco, Western Australia
Institut Jules Bordet-Medicine Oncology ( Site 0321), Bruxelles, Bruxelles-Capitale, Region De
Grand Hôpital de Charleroi-Oncology & Hematology ( Site 0323), Charleroi, Hainaut
Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman ( Site 0320), Liège, Liege
Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 3005), Natal, Rio Grande Do Norte
ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 3001), São Paulo, Sao Paulo
A. C. Camargo Cancer Center-CAPEC ( Site 3003), Sao Paulo, Not set
Cross Cancer Institute ( Site 0513), Edmonton, Alberta
BC Cancer Kelowna ( Site 0517), Kelowna, British Columbia
BC Cancer Vancouver-Clinical Trials Unit ( Site 0518), Vancouver, British Columbia
Sunnybrook Health Sciences - Odette Cancer Centre ( Site 0509), Toronto, Ontario
Princess Margaret Cancer Centre ( Site 0510), Toronto, Ontario
Jewish General Hospital ( Site 0504), Montreal, Quebec
Centre Hospitalier de l'Université de Montréal ( Site 0519), Montréal, Quebec
McGill University Health Centre ( Site 0505), Montréal, Quebec
Saskatoon Cancer Center-Clinical Research Department ( Site 0520), Saskatoon, Saskatchewan
FALP-UIDO ( Site 0602), Santiago, Region M. De Santiago
Pontificia Universidad Catolica de Chile-Centro del Cáncer ( Site 0604), Santiago, Region M. De Santiago
Bradfordhill-Clinical Area ( Site 0603), Santiago, Region M. De Santiago
Anhui Provincial Hospital-Obstetrics and Gynecology ( Site 0730), Hefei, Anhui
Beijing Obstetric and Gynecology Hospital ( Site 0740), Beijing, Beijing
Peking University First Hospital ( Site 0723), Beijing, Beijing
Beijing Cancer hospital ( Site 0715), Beijing, Beijing
Southwest Hospital of Third Military Medical University ( Site 0719), Chongqing, Chongqing
2nd Affiliated Hospital Chongqing Medical Universi ( Site 0745), Chongqing, Chongqing
Fuling Central Hospital ( Site 0733), Fulingqu, Chongqing
Fujian Provincial Cancer Hospital ( Site 0720), Fuzhou, Fujian
SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 0710), Guangzhou, Guangdong
Cancer Hospital of Shantou University Medical College ( Site 0732), Shantou, Guangdong
Affiliated Hospital of Guangdong Medical College ( Site 0731), Zhanjiang, Guangdong
Guangxi Medical University Affiliated Tumor Hospital-Gynecological oncology ( Site 0704), Nanning, Guangxi
Hainan General Hospital ( Site 0703), Haikou, Hainan
Harbin Medical University Cancer Hospital ( Site 0711), Harbin, Heilongjiang
Henan Cancer Hospital ( Site 0713), Zhengzhou, Henan
Wuhan Union Hospital-Medical Oncology ( Site 0716), Wuhan, Hubei
Xiangya Hospital Central South University-Gynecology ( Site 0708), Changsha, Hunan
Hunan Cancer Hospital ( Site 0709), Changsha, Hunan
Jiangsu Province Hospital-Oncology Department ( Site 0707), Nanjing, Jiangsu
The First Affiliated Hospital of Nanchang University ( Site 0729), Nanchang, Jiangxi
The First Hospital of Jilin University ( Site 0705), Changchun, Jilin
Shaanxi Provincial Cancer Hospital ( Site 0714), XI An, Shaanxi
Binzhou Medical University Hospital-Oncology department ( Site 0735), Binzhou, Shandong
Obstetrics & Gynecology Hospital of Fudan University ( Site 0702), Shanghai, Shanghai
Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 0717), Shanghai, Shanghai
West China Second University Hospital Sichuan University ( Site 0701), Chengdu, Sichuan
Tianjin Medical University Cancer Institute and Hospital ( Site 0706), Tianjin, Tianjin
Yunnan Province Cancer Hospital-Gynecology Department ( Site 0721), Kunming, Yunnan
The Affiliated Women's Hospital of Zhejiang University-Obstetrics and Gynecology ( Site 0726), Hangzhou, Zhejiang
Zhejiang Cancer Hospital-Oncology ( Site 0700), Hangzhou, Zhejiang
The First Affiliated Hospital of Wenzhou Medical University-Gynecology ( Site 0725), Wenzhou, Zhejiang
Fakultní nemocnice Brno Bohunice-Gynekologicko-porodnicka klinika ( Site 0404), Brno, Brno-mesto
Fakultni nemocnice Ostrava-Gynekologicko-porodnicka klinika ( Site 0403), Ostrava, Moravskoslezsky Kraj
Nemocnice AGEL Novy Jicin a.s.-Oddeleni radioterapie a onkologie ( Site 0406), Nový Jiín, Novy Jicin
Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0402), Olomouc, Olomoucky Kraj
Vseobecna fakultni nemocnice v Praze-Gynekologicko-porodnicka klinika 1.LF a VFN ( Site 0405), Praha, Praha 2
Fakultni nemocnice Bulovka-Gynekologicko-porodnicka klinika ( Site 0401), Praha, Praha 8
Nemocnice Tomase Bati ve Zline-Onkologické oddělení ( Site 0407), Zlín, Zlinsky Kraj
Fakultni nemocnice Kralovske Vinohrady-Gynekologicko-porodnická klinika ( Site 0408), Praha 10, Not set
Rigshospitalet ( Site 0903), Copenhagen, Hovedstaden
Herlev and Gentofte Hospital ( Site 0902), Copenhagen, Hovedstaden
Aalborg Universitetshospital, Syd ( Site 0905), Aalborg, Nordjylland
Roskilde Sygehus-Oncology department ( Site 0904), Roskilde, Sjaelland
Tampereen yliopistollinen sairaala-Gynecology and Obstetrics ( Site 1001), Tampere, Pirkanmaa
Kuopion Yliopistollinen Sairaala ( Site 1002), Kuopio, Pohjois-Savo
Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus) ( Site 1003), Helsinki, Uusimaa
Universitaetsklinikum Ulm ( Site 1106), Ulm, Baden-Wurttemberg
Universitätsklinikum Bonn-Gynaecological oncology ( Site 1105), Bonn, Nordrhein-Westfalen
Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Frauenheilkunde und Gebur, Dresden, Sachsen
Charité Campus Virchow-Klinikum ( Site 1103), Berlin, Not set
Országos Onkológiai Intézet-Ngyógyászat ( Site 1201), Budapest, Not set
Bon Secours Cork Hospital ( Site 1305), Cork, Not set
St. James's Hospital-Cancer clinical trials office ( Site 1301), Dublin, Not set
Soroka Medical Center ( Site 1403), Be'er Sheva, Not set
Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402), Haifa, Not set
Edith Wolfson Medical Center-Obstetrics & Gynecology ( Site 1405), Holon, Not set
Shaare Zedek Medical Center ( Site 1404), Jerusalem, Not set
Sheba Medical Center ( Site 1401), Ramat Gan, Not set
Istituto Nazionale Tumori IRCCS Fondazione Pascale-S.C. Oncologia Sperimentale Uro-Genitale ( Site 1, Napoli, Campania
IRCCS - AOU di Bologna-SSD Oncologia medica Addarii ( Site 1503), Bologna, Emilia-Romagna
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Oncologia Medica ( Site 1513), Meldola, Emilia-Romagna
Fondazione Policlinico Universitario Agostino Gemelli-Ginecologia Oncologica ( Site 1502), Roma, Lazio
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Chirurgia Ginecologica ( Site 150, Milan, Lombardia
Ospedale Mauriziano-SCDU ONCOLOGIA MEDICA ( Site 1514), Torino, Piemonte
Istituto Nazionale Tumori Regina Elena-Oncologia Medica 1 ( Site 1504), Rome, Roma
Azienda Ospedaliera Universitaria Careggi-SOD ONCOLOGIA MEDICA ( Site 1509), Firenze, Toscana
AULSS8 Berica-Ospedale S.Bortolo-ONCOLOGIA CLINICA ( Site 1510), Vicenza, Veneto
Istituto Europeo di Oncologia IRCCS-Divisione di Ginecologia Oncologica ( Site 1506), Milano, Not set
National Cancer Center Hospital East ( Site 1604), Kashiwa, Chiba
National Hospital Organization Shikoku Cancer Center ( Site 1611), Matsuyama, Ehime
Ehime University Hospital ( Site 1614), Toon, Ehime
Kurume University Hospital ( Site 1612), Kurume, Fukuoka
Gunma Prefectural Cancer Center-Gynecology ( Site 1603), Ota, Gunma
Hokkaido University Hospital ( Site 1601), Sapporo, Hokkaido
Tsukuba University Hospital ( Site 1618), Tsukuba, Ibaraki
Iwate Medical University Hospital ( Site 1602), Shiwa-gun Yahaba-cho, Iwate
Niigata University Medical & Dental Hospital ( Site 1613), Chuo-ku, Niigata, Niigata
Saitama Medical University International Medical Center ( Site 1605), Hidaka-shi, Saitama
Shizuoka Cancer Center ( Site 1609), Nagaizumi-cho,Sunto-gun, Shizuoka
National Cancer Center Hospital ( Site 1607), Chuo-ku, Tokyo
Japanese Foundation for Cancer Research ( Site 1616), Koto, Tokyo
The Jikei University Hospital ( Site 1615), Minato-ku, Tokyo
Keio university hospital ( Site 1606), Shinjyuku-ku, Tokyo
National Hospital Organization Kyushu Cancer Center ( Site 1608), Fukuoka, Not set
Osaka International Cancer Institute ( Site 1617), Osaka, Not set
Seoul National University Hospital ( Site 2302), Seoul, Not set
Severance Hospital, Yonsei University Health System-Gynecologic cancer center ( Site 2301), Seoul, Not set
Asan Medical Center-Division of Gynecologic Oncology, Dept. of Obstetrics & Gynecology ( Site 2303), Seoul, Not set
Gangnam Severance Hospital ( Site 2304), Seoul, Not set
Radboudumc-Medical Oncology ( Site 1703), Nijmegen, Gelderland
Maastricht UMC+ ( Site 1709), Maastricht, Limburg
Catharina Ziekenhuis-Oncology ( Site 1704), Eindhoven, Noord-Brabant
Amsterdam UMC, locatie AMC ( Site 1706), Amsterdam, Noord-Holland
Leids Universitair Medisch Centrum-Medical Oncology ( Site 1702), Leiden, Zuid-Holland
Erasmus Medisch Centrum-Medical Oncology ( Site 1701), Rotterdam, Zuid-Holland
University Medical Center Groningen ( Site 1707), Groningen, Not set
Universitair Medisch Centrum Utrecht-Medical Oncology ( Site 1705), Utrecht, Not set
Auckland City Hospital-Cancer & Blood Research ( Site 1801), Auckland, Not set
Oslo universitetssykehus, Radiumhospitalet ( Site 1901), Oslo, Not set
Centrum Onkologii Ziemi Lubelskiej ( Site 2006), Lublin, Lubelskie
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2007), Siedlce, Mazowieckie
Szpital Kliniczny im. Księżnej Anny Mazowieckiej ( Site 2009), Warsaw, Mazowieckie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit, Warszawa, Mazowieckie
Bialostockie Centrum Onkologii-Oddzial Onkologii Ginekologicznej ( Site 2003), Bialystok, Podlaskie
Narodowy Instytut Onkologii - Oddzial w Gliwicach-III Klinika Radioterapii i Chemioterapii ( Site 20, Gliwice, Slaskie
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej ( Site 2010), Kielce, Swietokrzyskie
Szpital Kliniczny im. Heliodora Święcickiego Uniwersytetu Me-Oddzial Ginekologii Onkologicznej ( Sit, Poznan, Wielkopolskie
Moscow City Oncology Hospital #62 ( Site 2204), Krasnogorsk, Moskovskaya Oblast
Yaroslavl Regional Cancer Hospital-Oncology ( Site 2202), Yaroslavl, Yaroslavskaya Oblast
Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2406), Hospitalet, Barcelona
CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 2405), A Coruña, La Coruna
Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 2402), Madrid, Madrid, Comunidad De
COMPLEJO HOSPITALARIO DE NAVARRA ( Site 2407), Pamplona, Navarra
Fundación Instituto Valenciano de Oncología-Oncologico ( Site 2404), Valencia, Valenciana, Comunitat
Hospital Universitari Vall d'Hebron ( Site 2403), Barcelona, Not set
HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO ( Site 2401), Sevilla, Not set
Skånes Universitetssjukhus Lund-Department of Hematology ( Site 2504), Lund, Skane Lan
Karolinska Universitetssjukhuset Solna ( Site 2502), Solna, Stockholms Lan
Norrlands universitetssjukhus-Cancercentrum ( Site 2503), Umeå, Vasterbottens Lan
Taichung Veterans General Hospital ( Site 2602), Taichung, Not set
NATIONAL CHENG-KUNG UNI. HOSP. ( Site 2604), Tainan, Not set
National Taiwan University Hospital ( Site 2603), Taipei, Not set
Mackay Memorial Hospital ( Site 2601), Taipei, Not set
Taipei Veterans General Hospital ( Site 2605), Taipei, Not set
Istanbul Universitesi Cerrahpasa ( Site 2702), Fatih, Istanbul
Hacettepe Universite Hastaneleri-oncology hospital ( Site 2704), Ankara, Not set
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 2706), Ankara, Not set
Akdeniz Universitesi Hastanesi ( Site 2701), Antalya, Not set
Istanbul University Capa Campus-department of obstetrics and gynaecology ( Site 2705), Istanbul, Not set
T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma, Istanbul, Not set
St Bartholomew's Hospital ( Site 2804), London, England
The Christie ( Site 2807), Manchester, England
The Beatson West of Scotland Cancer Centre ( Site 2805), Glasgow, Glasgow City
ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 2806), London, London, City Of
Hammersmith Hospital-Medical Oncology ( Site 2808), London, London, City Of
Conditions: Endometrial Neoplasms
An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
Completed
The purpose of this study is to show that Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus Platinum-Doublet Chemotherapy improves progression free survival and/or overall survival compared with chemotherapy in patients with advanced lung cancer.
The purpose of this study is to show that Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus Platinum-Doublet Chemotherapy improves progression free survival and/or overall survival compared with chemotherapy in patients with advanced lung cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/16/2024
Locations: Southern Cancer Center, Inc., Mobile, Alabama +289 locations
Southern Cancer Center, Inc., Mobile, Alabama
Local Institution - 0017, San Francisco, California
Local Institution - 0021, New Haven, Connecticut
Local Institution - 0001, Atlanta, Georgia
Local Institution - 0013, Marietta, Georgia
Local Institution - 0004, Lexington, Kentucky
Local Institution - 0115, Saint Louis, Missouri
Local Institution - 0005, Buffalo, New York
Local Institution - 0019, New York, New York
Local Institution - 0014, Cleveland, Ohio
Local Institution - 0009, Columbus, Ohio
Local Institution - 0007, Allentown, Pennsylvania
Local Institution - 0075, Langhorne, Pennsylvania
Local Institution - 0299, Philadelphia, Pennsylvania
Local Institution - 0012, Philadelphia, Pennsylvania
Local Institution - 0015, Sayre, Pennsylvania
Local Institution - 0008, Charleston, South Carolina
Local Institution - 0080, Greenville, South Carolina
Local Institution - 0010, Greenville, South Carolina
Local Institution - 0020, Nashville, Tennessee
Local Institution - 0306, Dallas, Texas
Local Institution - 0003, Dallas, Texas
Local Institution - 0102, Houston, Texas
Local Institution - 0011, Salt Lake City, Utah
Local Institution - 0074, Kennewick, Washington
Local Institution - 0170, Berazategui, Buenos Aires
Local Institution - 0171, Capital Federal, Buenos Aires
Local Institution - 0172, Ciudad Autonoma De Buenos Aire, Buenos Aires
Local Institution - 0176, Ciudad de Buenos Aires, Buenos Aires
Local Institution - 0296, Mar Del Plata, Buenos Aires
Local Institution - 0177, Viedma, RIO Negro
Local Institution - 0130, San Miguel de Tucuman, Tucuman
Local Institution - 0268, Cordoba, Not set
Local Institution - 0272, Córdoba, Not set
Local Institution - 0297, Córdoba, Not set
Local Institution - 0182, Garran, Australian Capital Territory
Local Institution - 0301, Blacktown, New South Wales
Local Institution - 0300, Gosford, New South Wales
Local Institution - 0045, Brisbane, Queensland
Local Institution - 0046, Elizabeth Vale, South Australia
Local Institution - 0043, Clayton, Victoria
Local Institution - 0042, Fitzroy, Victoria
Local Institution - 0180, Perth, Western Australia
Local Institution - 0040, Murdoch, Not set
Local Institution - 0183, North Tamworth, Not set
Local Institution - 0241, Graz, Not set
Local Institution - 0240, Vienna, Not set
Local Institution - 0239, Wels, Not set
Local Institution - 0121, Roeselare, West-Vlaanderen
Local Institution - 0030, Edegem, Not set
Local Institution - 0031, Gent, Not set
Local Institution - 0034, Gilly, Not set
Local Institution - 0117, Hasselt, Not set
Local Institution - 0033, Sint Niklaas, Not set
Local Institution - 0125, Salvador, Bahia
Local Institution - 0124, Ijui, RIO Grande DO SUL
Local Institution - 0123, Porto Alegre, Rio Grande Do Sul
Local Institution - 0127, Barretos, Sao Paulo
Local Institution - 0129, Rio De Janeiro, Not set
Local Institution - 0144, Sao Paulo, Not set
Local Institution - 0126, Sao Paulo, Not set
Local Institution - 0128, Sao Paulo, Not set
Local Institution - 0103, Edmonton, Alberta
Local Institution - 0290, St. John's, Newfoundland and Labrador
Local Institution - 0104, London, Ontario
Local Institution - 0122, Montreal, Quebec
Local Institution - 0106, Quebec City, Quebec
Local Institution - 0107, Rimouski, Quebec
Local Institution - 0291, Sherbrooke, Quebec
Local Institution - 0292, Trois-Rivieres, Quebec
Local Institution - 0302, Quebec, Not set
Local Institution - 0173, Santiago, Metropolitana
Local Institution - 0131, Santiago, Región Metropolitana De Santiago
Local Institution - 0174, Vina Del Mar, Valparaiso
Local Institution - 0380, Hefei, Anhui
Local Institution - 0313, Beijing, Beijing
Local Institution - 0315, Beijing, Beijing
Local Institution - 0316, Beijing, Beijing
Local Institution - 0314, Beijing, Beijing
Local Institution - 0365, Chongqing, Chongqing
Local Institution - 0364, Chongqing, Chongqing
Local Institution - 0378, Chongqing, Chongqing
Local Institution - 0322, Guangzhou, Guangdong
Local Institution - 0372, Guangzhou, Guangdong
Local Institution - 0319, Guanzhou, Guangdong
Local Institution - 0323, Haikou, Hainan
Local Institution - 0325, Haerbin, Heilongjiang
Local Institution - 0324, Zhengzhou, Henan
Local Institution - 0379, Zhengzhou, Henan
Local Institution - 0375, Wuhan, Hubei
Local Institution - 0362, Changsha, Hunan
Local Institution - 0347, Nanchang, Jiangxi
Local Institution - 0329, Changchun, Jilin
Local Institution - 0361, Changchun, Jilin
Local Institution - 0359, Shenyang, Liaoning
Local Institution - 0371, Xi'an, Shaanxi
Local Institution - 0333, Xi'an, Shan3xi
Local Institution - 0360, Qingdao, Shandong
Local Institution - 0334, Shanghai, Shanghai
Local Institution - 0376, Chengdu, Sichuan
Local Institution - 0373, Tianjin, Tianjin
Local Institution - 0340, Urumqi, Xinjiang
Local Institution - 0343, Hangzhou, Zhejiang
Local Institution - 0370, Hangzhou, Zhejiang
Local Institution - 0342, Hangzhou, Zhejiang
Local Institution - 0328, Changsha, Not set
Local Institution - 0341, Hangzhou, Not set
Local Institution - 0345, Kunming, Not set
Local Institution - 0336, Shanghai, Not set
Local Institution - 0337, Shanghai, Not set
Local Institution - 0374, Shantou, Not set
Local Institution - 0273, Pereira, Risaralda
Local Institution - 0237, Bogota, Not set
Local Institution - 0238, Bogota, Not set
Local Institution - 0282, Medellin, Not set
Local Institution - 0112, Hradec Kralove, Not set
Local Institution - 0113, Olomouc, Not set
Local Institution - 0111, Praha 4, Not set
Local Institution - 0232, Pribram, Not set
Local Institution - 0270, Oulu, Not set
Local Institution - 0271, Turku, Not set
Local Institution - 0222, Bron, Rhône
Local Institution - 0216, ANGERS Cedex 2, Not set
Local Institution - 0229, Besançon Cedex, Not set
Local Institution - 0283, Caen, Not set
Local Institution - 0218, Creteil, Not set
Local Institution - 0228, Limoges, Not set
Local Institution - 0215, Marseille Cedex 20, Not set
Local Institution - 0230, Paris, Not set
Local Institution - 0227, Pessac, Not set
Local Institution - 0223, Rennes, Not set
Local Institution - 0225, Rouen, Not set
Local Institution - 0221, Saint Priest En Jarez, Not set
Local Institution - 0217, Saint-herblain Cedex, Not set
Local Institution - 0224, Strasbourg, Not set
Local Institution - 0226, Toulon, Not set
Local Institution - 0231, Magdeburg, Sachsen-Anhalt
Local Institution - 0213, Bad Berka, Not set
Local Institution - 0208, Berlin, Not set
Local Institution - 0205, Essen, Not set
Local Institution - 0210, Frankfurt, Not set
Local Institution - 0211, Gera, Not set
Local Institution - 0203, Grosshansdorf, Not set
Local Institution - 0209, Halle, Not set
Local Institution - 0202, Heidelberg, Not set
Local Institution - 0214, Hemer, Not set
Local Institution - 0206, Immenstadt, Not set
Local Institution - 0204, Muenchen, Not set
Local Institution - 0201, Stuttgart, Not set
Local Institution - 0212, Wiesbaden, Not set
Local Institution - 0094, Athens, Attikí
Local Institution - 0095, Heraklion, Not set
Local Institution - 0190, Neo Faliro, Not set
Local Institution - 0101, Thessaloniki, Not set
Local Institution - 0025, Budapest, Not set
Local Institution - 0024, Budapest, Not set
Local Institution - 0026, Matrahaza, Not set
Local Institution - 0054, Dublin 8, Dublin
Local Institution - 0053, Beaumont, Not set
Local Institution - 0055, Galway, Not set
Local Institution - 0100, Limerick, Not set
Local Institution - 0187, Jerusalem, Not set
Local Institution - 0186, Kfar-saba, Not set
Local Institution - 0185, Petach Tikva, Not set
Local Institution - 0184, Tel-hashomer, Not set
Local Institution - 0188, Zerifin, Not set
Local Institution - 0083, Milan, Lombardia
Azienda Ospedaliera Moscati, Avellino, Not set
Local Institution - 0179, Bergamo, Not set
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set
Local Institution - 0084, Livorno, Not set
Policlinico G. Martino, Messina, Not set
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set
Istituto Nazionale Tumori Fondazione Pascale, Napoli, Not set
Local Institution - 0087, Perugia, Not set
Ospedale Santa Maria delle Croci, Ravenna, Not set
Ifo-Istituto Regina Elena, Roma, Not set
Local Institution - 0089, Roma, Not set
Local Institution - 0085, Terni, Not set
Local Institution - 0153, Nagoya-shi, Aichi
Local Institution - 0152, Nagoya, Aichi
Local Institution - 0148, Kashiwa-shi, Chiba
Local Institution - 0159, Matsuyama, Ehime
Local Institution - 0160, Fukuoka-shi, Fukuoka
Local Institution - 0259, Kurume-shi, Fukuoka
Local Institution - 0255, Ota-shi, Gunma
Local Institution - 0258, Hiroshima-shi, Hiroshima
Local Institution - 0163, Sapporo-shi, Hokkaido
Local Institution - 0253, Sapporo-shi, Hokkaido
Local Institution - 0252, Akashi-shi, Hyogo
Local Institution - 0156, Kobe-shi, Hyogo
Local Institution - 0146, Kanazawa-shi, Ishikawa
Local Institution - 0161, Yokohama-shi, Kanagawa
Local Institution - 0150, Yokohama-Shi, Kanagawa
Local Institution - 0275, Natori-shi, Miyagi
Local Institution - 0254, Sendai-shi, Miyagi
Local Institution - 0145, Sendai-shi, Miyagi
Local Institution - 0164, Niigata-shi, Niigata
Local Institution - 0158, Kurashiki-shi, Okayama
Local Institution - 0155, Hirakata-shi, Osaka
Local Institution - 0154, Osaka-shi, Osaka
Local Institution - 0251, Osakasayama-shi, Osaka
Local Institution - 0257, Takatsuki-shi, Osaka
Local Institution - 0353, Hidaka-shi, Saitama
Local Institution - 0256, Kitaadachi-gun, Saitama
Local Institution - 0151, Sunto-gun, Shizuoka
Local Institution - 0147, Chuo-ku, Tokyo
Local Institution - 0149, Koto-ku, Tokyo
Local Institution - 0278, Shinjuku-ku, Tokyo
Local Institution - 0157, Wakayama-shi, Wakayama
Local Institution - 0354, Ube-shi, Yamaguchi
Local Institution - 0260, Chiba, Not set
Local Institution - 0165, Okayama, Not set
Local Institution - 0162, Tokyo, Not set
Local Institution - 0136, Seongnam-si, Kyǒnggi-do
Local Institution - 0249, Cheongju-si, Not set
Local Institution - 0133, Gangnam-gu, Not set
Local Institution - 0132, Seoul, Not set
Local Institution - 0135, Seoul, Not set
Local Institution - 0287, Beirut, Not set
Local Institution - 0286, Beirut, Not set
Local Institution - 0196, Df, Distrito Federal
Local Institution - 0193, Mexico, Distrito Federal
Local Institution - 0198, Cuautitlan, Estado DE Mexico
Local Institution - 0197, Guadalajara, Jalisco
Local Institution - 0191, Zapopan, Jalisco
Local Institution - 0267, Morelia, Michoacan
Local Institution - 0277, Monterrey, Nuevo Leon
Local Institution - 0303, Merida, Yucatán
Local Institution - 0192, Chihuahua, Not set
Local Institution - 0195, San Luis Potosi, Not set
Local Institution - 0236, San Luis Potosi, Not set
Local Institution - 0194, Toluca, Not set
Local Institution - 0036, Amsterdam, Not set
Local Institution - 0189, Amsterdam, Not set
Local Institution - 0169, Breda, Not set
Local Institution - 0037, Rotterdam, Not set
Local Institution - 0039, Veldhoven, Not set
Local Institution - 0262, Lima, Not set
Local Institution - 0263, Lima, Not set
Local Institution - 0350, Lima, Not set
Local Institution - 0261, Lima, Not set
Local Institution - 0351, Lima, Not set
Local Institution - 0060, Bydgoszcz, Not set
Local Institution - 0058, Gdansk, Not set
Local Institution - 0063, Gdynia, Not set
Local Institution - 0072, Gliwice, Not set
Local Institution - 0057, Lodz, Not set
Local Institution - 0059, Warszawa, Not set
Local Institution - 0070, Wroclaw, Not set
Local Institution - 0167, Craiova, Not set
Local Institution - 0250, Floresti, Not set
Local Institution - 0166, Romania, Not set
Local Institution - 0284, Sector 2, Not set
Local Institution - 0137, Chelyabinsk, Not set
Local Institution - 0142, Kazan, Not set
Local Institution - 0022, Moscow, Not set
Local Institution - 0049, Saint-Petersburg, Not set
Local Institution - 0028, St. Petersburg, Not set
Local Institution - 0027, St. Petersburg, Not set
Local Institution - 0143, Ufa, Not set
Local Institution - 0264, Pretoria, Gauteng
Local Institution - 0234, Sandton, Gauteng
Local Institution - 0233, Saxonwold, Johannesburg, Gauteng
Local Institution - 0305, Vereeniging, Not set
Local Institution - 0064, Majadahonda, Madrid
Local Institution - 0066, Barcelona, Not set
Local Institution - 0067, Barcelona, Not set
Local Institution - 0065, Madrid, Not set
Local Institution - 0069, Sevilla, Not set
Local Institution - 0068, Valencia, Not set
Local Institution - 0243, Basel, Not set
Local Institution - 0246, Chur, Not set
Local Institution - 0244, Lausanne, Not set
Local Institution - 0245, Winterthur, Not set
Local Institution - 0139, Taichung, Not set
Local Institution - 0138, Taipei, Not set
Local Institution - 0140, Taipei, Not set
Local Institution - 0310, Taipei, Not set
Local Institution - 0141, Taoyuan city, Not set
Local Institution - 0266, Middlesborough, Cleveland
Local Institution - 0098, London, Greater London
Local Institution - 0099, Southampton, Hampshire
Local Institution - 0118, Leicester, Leicestershire
Local Institution - 0265, Birmingham, Not set
Local Institution - 0051, Cambridgeshire, Not set
Local Institution - 0109, Edinburgh, Not set
Local Institution - 0097, London, Not set
Local Institution - 0050, London, Not set
Local Institution - 0119, Surrey, Not set
Conditions: Non-Small Cell Lung Cancer
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
Active Not Recruiting
The purpose of this study is to assess the efficacy and safety of pembrolizumab in combination with concurrent chemoradiation therapy followed by either pembrolizumab with olaparib placebo (Arm 1) or with olaparib (Arm 2) compared to concurrent chemoradiation therapy followed by durvalumab (Arm 3) in participants with unresectable, locally advanced NSCLC. Arms 1 and 2 will be studied in a double-blind design and Arm 3 will be open-label. The primary hypotheses are:
1. Pembrolizumab with concurr... Read More
The purpose of this study is to assess the efficacy and safety of pembrolizumab in combination with concurrent chemoradiation therapy followed by either pembrolizumab with olaparib placebo (Arm 1) or with olaparib (Arm 2) compared to concurrent chemoradiation therapy followed by durvalumab (Arm 3) in participants with unresectable, locally advanced NSCLC. Arms 1 and 2 will be studied in a double-blind design and Arm 3 will be open-label. The primary hypotheses are:
1. Pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab with olaparib is superior to concurrent chemoradiation therapy followed by durvalumab with respect to progression-free survival (PFS) and overall survival (OS)
2. Pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab is superior to concurrent chemoradiation therapy followed by durvalumab with respect to PFS and OS Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/15/2024
Locations: University of South Alabama, Mitchell Cancer Institute ( Site 0003), Mobile, Alabama +204 locations
University of South Alabama, Mitchell Cancer Institute ( Site 0003), Mobile, Alabama
St. Bernards Medical Center ( Site 0089), Jonesboro, Arkansas
St Joseph Heritage Healthcare-Oncology ( Site 0088), Fullerton, California
Long Beach Memorial Medical Center ( Site 0006), Long Beach, California
UCLA Hematology/Oncology - Santa Monica ( Site 0013), Los Angeles, California
St. Joseph Heritage Healthcare Local Lab ( Site 0011), Santa Rosa, California
Torrance Memorial Physician Network / Cancer Center ( Site 0093), Torrance, California
Memorial Regional Hospital-Memorial Cancer Institute ( Site 0095), Hollywood, Florida
Miami VA Healthcare System ( Site 0024), Miami, Florida
Mid Florida Hematology and Oncology Center ( Site 0022), Orange City, Florida
Orlando Health, UF Health Cancer Center Inc ( Site 0092), Orlando, Florida
Fort Wayne Medical Oncology and Hematology ( Site 0094), Fort Wayne, Indiana
Parkview Research Center ( Site 0032), Fort Wayne, Indiana
Franciscan Health Lafayette East ( Site 0031), Lafayette, Indiana
University of Kentucky ( Site 0096), Lexington, Kentucky
Norton Brownsboro Hospital-Norton Cancer Institute - Brownsboro ( Site 0035), Louisville, Kentucky
Pikeville Medical Center ( Site 0036), Pikeville, Kentucky
Massachusetts General Hospital ( Site 0038), Boston, Massachusetts
Henry Ford Hospital ( Site 0045), Detroit, Michigan
VA St. Louis Health Care System ( Site 0047), Saint Louis, Missouri
Washington University Siteman Cancer Center ( Site 0046), Saint Louis, Missouri
CHI Health St. Francis ( Site 0053), Grand Island, Nebraska
Rutgers Cancer Institute of New Jersey ( Site 0054), New Brunswick, New Jersey
The Valley Hospital ( Site 0056), Paramus, New Jersey
Montefiore Einstein Center ( Site 0083), Bronx, New York
Novant Health Presbyterian ( Site 0081), Charlotte, North Carolina
Duke University Medical Center ( Site 0050), Durham, North Carolina
Piedmont Hematology-Oncology Associates ( Site 0080), Winston-Salem, North Carolina
The Lindner Center for Research and Education at The Christ Hospital ( Site 0060), Cincinnati, Ohio
Fox Chase Cancer Center ( Site 0063), Philadelphia, Pennsylvania
Sanford Cancer Center Oncology Clinic ( Site 0066), Sioux Falls, South Dakota
Veterans Affairs Puget Sound Health Care System [Seattle, WA] ( Site 0075), Seattle, Washington
Cancer Care Northwest ( Site 0074), Spokane Valley, Washington
Instituto Médico Río Cuarto ( Site 4003), Río Cuarto, Cordoba
Clinica Adventista Belgrano-Oncology ( Site 4002), Caba, Not set
Queen Elizabeth II Health Sciences Centre ( Site 0100), Halifax, Nova Scotia
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0102), Montreal, Quebec
CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0108), Montreal, Quebec
McGill University Health Center - Research Institute ( Site 0114), Montreal, Quebec
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Quebec, Not set
Centro Investigación del Cáncer James Lind ( Site 0202), Temuco, Araucania
OrlandiOncologia ( Site 0201), Santiago, Region M. De Santiago
Bradfordhill ( Site 0200), Santiago, Region M. De Santiago
Oncocentro ( Site 0203), Vina del Mar, Valparaiso
Bradford Hill Norte ( Site 0204), Antofagasta, Not set
Beijing Cancer Hospital ( Site 3224), Beijing, Beijing
Peking Union Medical College Hospital ( Site 3201), Beijing, Beijing
Cancer Hospital Chinese Academy of Medical Sciences ( Site 3213), Beijing, Beijing
Beijing Cancer Hospital ( Site 3212), Beijing, Beijing
Daping Hospital,Third Military Medical University ( Site 3235), Chongqing, Chongqing
Fujian Provincial Cancer Hospital ( Site 3226), Fuzhou, Fujian
The First Affiliated Hospital of Xiamen University ( Site 3219), Xiamen, Fujian
Peking University Shenzhen Hospital ( Site 3216), Shenzhen, Guangdong
Cancer Hospital Chinese Academy Of Medical Sciences. Shenzhen Center ( Site 3200), Shenzhen, Guangdong
Henan Cancer Hospital ( Site 3205), Zhengzhou, Henan
Wuhan Union Hospital ( Site 3222), Wuhan, Hubei
Hubei Cancer Hospital ( Site 3218), Wuhan, Hubei
Hunan Cancer Hospital ( Site 3238), Changsha, Hunan
Xiangya Hospital of Central South University ( Site 3637), Changsha, Hunan
Second Xiangya Hospital of Central-South University ( Site 3227), Changsha, Hunan
Hunan Cancer Hospital ( Site 3225), Changsha, Hunan
Jiangsu Cancer Hospital ( Site 3234), Nanjing, Jiangsu
The Second Affiliated Hospital of Nanchang University ( Site 3206), Nanchang, Jiangxi
Jilin Cancer Hospital ( Site 3230), Changchun, Jilin
Shanghai Chest Hospital ( Site 3207), Shangai, Shanghai
Zhongshan Hospital Fudan University ( Site 3220), Shanghai, Shanghai
Shanghai Pulmonary Hospital ( Site 3203), Shanghai, Shanghai
West China Hospital of Sichuan University ( Site 3202), Chengdu, Sichuan
Tianjin Medical University Cancer Institute & Hospital ( Site 3204), Tianjin, Tianjin
The 1st Affil Hosp of College of Medicine, Zhejiang Univ ( Site 3232), Hangzhou, Zhejiang
Masarykuv onkologicky ustav ( Site 2206), Brno, Brno-mesto
Fakultni nemocnice Ostrava ( Site 2201), Ostrava, Ostrava Mesto
Fakultni nemocnice Kralovske Vinohrady-Radioterapeuticka a onkologicka klinika ( Site 2200), PRague, Praha 10
Fakultni nemocnice v Motole ( Site 2210), Praha, Praha, Hlavni Mesto
Nemocnice Na Plesi s.r.o. ( Site 2202), Nova Ves pod Plesi, Pribram
Krajska nemocnice Liberec, a.s. ( Site 2209), Liberec, Not set
Vseobecna fakultni nemocnice v Praze ( Site 2208), Praha 2, Not set
Nemocnice Na Bulovce ( Site 2205), Praha 8, Not set
North Estonia Medical Centre Foundation ( Site 1601), Tallin, Harjumaa
Tartu University Hospital ( Site 1600), Tartu, Tartumaa
Clinique Clairval ( Site 0802), Marseille, Bouches-du-Rhone
C.H.R.U. de Brest - Hopital Morvan ( Site 0806), Brest, Bretagne
Centre Hospitalier Annecy Genevois ( Site 0811), Epagny Metz Tessy, Haute-Savoie
Clinique Teissier Groupe ( Site 0808), Valenciennes, Nord
Hopital Avicenne ( Site 0803), Bobigny, Seine-Saint-Denis
Clinique de l'Europe-Service de pneumologie ( Site 0816), Amiens, Somme
H.I.A. Sainte-Anne ( Site 0815), Toulon, Var
CHD Vendee ( Site 0807), La Roche sur Yon, Vendee
Universitätsmedizin Göttingen - Georg-August-Universität ( Site 0917), Göttingen, Niedersachsen
Johannes Wesling Klinikum Minden ( Site 0908), Minden, Nordrhein-Westfalen
GEHO Muenster ( Site 0910), Muenster, Nordrhein-Westfalen
Johanna Etienne Hospital-Klinik für Onkologie ( Site 0916), Neuss, Nordrhein-Westfalen
LungenClinic Grosshansdorf GmbH ( Site 0901), Grosshansdorf, Schleswig-Holstein
Zentralklinik Bad Berka GmbH ( Site 0905), Bad Berka, Thuringen
Universitaetsklinikum Jena ( Site 0911), Jena, Thuringen
Charite-Universitaetsmedizin Berlin Campus Virchow-Klinikum ( Site 0900), Berlin, Not set
Katholisches Marienkrankenhaus gGmbH ( Site 0902), Hamburg, Not set
Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 2302), Kecskemét, Bacs-Kiskun
Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 2303), Gyula, Bekes
Petz Aladar Megyei Oktato Korhaz ( Site 2306), Gyor, Gyor-Moson-Sopron
Orszagos Koranyi Pulmonologiai Intezet ( Site 2305), Budapest, Not set
Országos Korányi Pulmonológiai Intézet-VI. Tüdöbelosztály és Bronchológia ( Site 2309), Budapest, Not set
Azienda Ospedaliera Umberto I- Torrette ( Site 1009), Torrette, Ancona
Azienda Ospedaliero Universitaria Careggi ( Site 1001), Florence, Firenze
Istituto Clinico Humanitas Research Hospital ( Site 1000), Rozzano, Lombardia
Azienda Ospedaliera Vito Fazzi ( Site 1003), Lecce, Not set
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1008), Milano, Not set
Policlinico di Modena ( Site 1007), Modena, Not set
Policlinico Agostino Gemelli ( Site 1002), Roma, Not set
A.O.U. Santa Maria della Misericordia di Udine ( Site 1004), Udine, Not set
Kurume University Hospital ( Site 3112), Kurume, Fukuoka
Kobe Minimally Invasive Cancer Center ( Site 3100), Kobe, Hyogo
Kanagawa Cancer Center ( Site 3101), Yokohama, Kanagawa
Kansai Medical University Hospital ( Site 3103), Hirakata, Osaka
Osaka Medical and Pharmaceutical University Hospital ( Site 3110), Takatsuki, Osaka
National Hospital Organization Kyushu Cancer Center ( Site 3104), Fukuoka, Not set
Niigata Cancer Center Hospital ( Site 3109), Niigata, Not set
Osaka International Cancer Institute ( Site 3106), Osaka, Not set
Juntendo University Hospital ( Site 3111), Tokyo, Not set
Tokyo Metropolitan Komagome Hospital ( Site 3108), Tokyo, Not set
The Cancer Institute Hospital of JFCR ( Site 3107), Tokyo, Not set
Showa University Hospital ( Site 3105), Tokyo, Not set
Chungbuk National University Hospital ( Site 2802), Cheongju-si, Chungbuk
National Cancer Center ( Site 2800), Goyang-si, Kyonggi-do
The Catholic University of Korea St. Vincent s Hospital ( Site 2805), Gyeonggi-do, Kyonggi-do
Seoul National University Bundang Hospital ( Site 2801), Seongnam-si, Kyonggi-do
Ajou University Hospital ( Site 2803), Suwon-si, Kyonggi-do
Gyeongsang National University Hospital ( Site 2804), Jinju-si, Kyongsangnam-do
Keimyung University Dongsan Hospital ( Site 2807), Daegu, Taegu-Kwangyokshi
Kangbuk Samsung Hospital ( Site 2806), Seoul, Not set
Severance Hospital Yonsei University Health System ( Site 2808), Seoul, Not set
Pauls Stradins Clinical University Hospital ( Site 1501), Riga, Not set
Riga East Clinical University Hospital ( Site 1500), Riga, Not set
Hospital of Lithuanian University of Health Sciences Kauno klinikos-Pulmonology ( Site 4201), Kaunas, Kauno Apskritis
National Cancer Institute-Department of Thoracic Surgery and Oncology ( Site 4200), Vilnius, Vilniaus Miestas
Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0500), Guadalajara, Jalisco
Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 0508), Monterrey, Nuevo Leon
CLIMERS Clinical Medical Research ( Site 0506), Orizaba, Veracruz
Instituto Nacional de Cancerologia ( Site 0502), Tlalpan, Not set
Akershus Universitetssykehus HF ( Site 1106), Lorenskog, Akershus
Vestre Viken HF Drammen Sykehus ( Site 1101), Drammen, Buskerud
Sykehuset Oestfold ( Site 1107), Gralum, Ostfold
Helse Stavanger HF Stavanger Universitetssjukehus ( Site 1103), Stavanger, Rogaland
Oslo Universitetssykehus HF. Ulleval ( Site 1100), Oslo, Not set
Hospital Nacional Carlos Alberto Seguin Escobedo ESSALUD ( Site 0604), Arequipa, Ariqipa
Oncosalud ( Site 0605), Lima, Muni Metro De Lima
Detecta Clínica ( Site 0607), Surquillo, Muni Metro De Lima
IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0606), Lima, Not set
Clinica San Gabriel ( Site 0601), Lima, Not set
Hospital Nacional Cayetano Heredia ( Site 0602), Lima, Not set
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2404), Siedlce, Mazowieckie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie
Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 2400), Gdynia, Pomorskie
SPZOZ MSWIA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie ( Site 2401), Olsztyn, Warminsko-mazurskie
Spitalul Universitar de Urgenta Bucuresti ( Site 2508), Bucharest, Bucuresti
Gral Medical SRL-Medical Oncology ( Site 2511), București, Bucuresti
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 2506), Cluj Napoca, Cluj
S.C. Radiotherapy Center Cluj S.R.L ( Site 2503), Comuna Floresti, Cluj
Centrul de Oncologie "Sfântul Nectarie"-Medical Oncology ( Site 2510), Craiova, Dolj
Radiology Therapeutic Center-Oncology ( Site 2502), Otopeni, Ilfov
Policlinica Oncomed SRL ( Site 2504), Timisoara, Timis
S C Oncocenter Oncologie Clinica S R L-Medical Oncology ( Site 2509), Timișoara, Timis
S.C.Focus Lab Plus S.R.L ( Site 2500), Bucuresti, Not set
Spitalul Clinic Judetean De Urgenta Constanta ( Site 2501), Constanta, Not set
Institutul Regional de Oncologie Iasi ( Site 2505), Iasi, Not set
Chelyabinsk Regional Clinical Oncological Dispensary ( Site 1913), Chelyabinsk, Chelyabinskaya Oblast
MSROI named after P.A. Hertsen branch of FSBI NMRC Radiology ( Site 1903), Moscow, Moskva
Nizhniy Novgorod Region Oncology Dispensary ( Site 1914), Nizhniy Novgorod, Nizhegorodskaya Oblast
Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 1905), Saint-Petersburg, Sankt-Peterburg
Medical institute named after Berezin Sergey ( Site 1906), St. Petersburg, Sankt-Peterburg
Sverdlovsk Regional Oncology Hospital ( Site 1909), Ekaterinburg, Sverdlovskaya Oblast
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1911), Kazan, Tatarstan, Respublika
Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 1910), Yaroslavl, Yaroslavskaya Oblast
Hospital Universitario Puerta de Hierro (Majadahonda) ( Site 1202), Majadahonda, Madrid
Hospital Universitario Quiron Madrid ( Site 1200), Pozuelo de Alarcon, Madrid
H.R.U Málaga - Hospital General ( Site 1206), Málaga, Malaga
H.U. Vall de Hebron ( Site 1201), Barcelona, Not set
Hospital Clinic de Barcelona ( Site 1204), Barcelona, Not set
Hospital Universitario Virgen Macarena ( Site 1205), Sevilla, Not set
Hospital Universitario La Fe ( Site 1203), Valencia, Not set
Chulalongkorn University ( Site 3003), Bangkok, Krung Thep Maha Nakhon
Ramathibodi Hospital. ( Site 3000), Bangkok, Krung Thep Maha Nakhon
Chiang Mai University Maharaj Nakorn Chiang Mai Hospital ( Site 3001), Chiang Mai, Not set
Srinagarind Hospital. Khon Kaen University ( Site 3002), Khon Kaen, Not set
Ankara Bilkent Sehir Hastanesi ( Site 2002), Ankara, Adana
Memorial Ankara Hastanesi ( Site 2006), Ankara, Not set
Istanbul Uni. Cerrahpasa Tip Fakultesi ( Site 2000), Istanbul, Not set
Medipol Universite Hastanesi ( Site 2003), Istanbul, Not set
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 2001), Istanbul, Not set
Ege University Medical Faculty ( Site 2005), Izmir, Not set
Medical center Medikal Plaza of Ecodnipro LLC ( Site 2107), Dnipro, Dnipropetrovska Oblast
SOGrigoriev Inst for Med Radiolgy and Oncology of NAMS of Ukraine-Clinical oncology and hematology (, Kharkiv, Kharkivska Oblast
Communal nonprofit enterprise "Kherson Regional Oncology Dispensary" of Kherson Regional Council (, Antonivka Village, Khersonska Oblast
LLC Ukrainian Center of Tomotherapy ( Site 2105), Kropyvnytskyi, Kirovohradska Oblast
Medical Center of Yuriy Spizhenko LLC.-Clinical Trial ( Site 2104), Kapitanivka Village, Kyivska Oblast
SNPE National Cancer Institute ( Site 2101), Kyiv, Kyivska Oblast
Medical Center Verum ( Site 2106), Kyiv, Kyivska Oblast
Kyiv City Clinical Oncology Center ( Site 2100), Kyiv, Not set
Weston Park Hospital ( Site 1406), Sheffield, Derbyshire
University College Hospital NHS Foundation Trust ( Site 1403), London-Camden, London, City Of
Guys and St Thomas NHS Foundation Trust ( Site 1410), London, London, City Of
Royal Marsden Hospital (Sutton) ( Site 1407), London, Surrey
Southampton General Hospital ( Site 1400), Southampton, Worcestershire
Leeds Teaching Hospitals NHS Trust ( Site 1401), Leeds, Not set
Christie NHS Foundation Trust ( Site 1409), Manchester, Not set
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Active Not Recruiting
This trial will evaluate the safety and efficacy of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant chemotherapy (NAC) before surgery \[neoadjuvant phase\], followed by pembrolizumab alone after surgery \[adjuvant phase\] in participants with resectable stage II, IIIA, and resectable IIIB (T3-4N2) non-small cell lung cancer (NSCLC). The primary hypotheses of this study are that neoadjuvant pembrolizumab (vs. placebo) in combination with NAC, followed by surgery and adjuv... Read More
This trial will evaluate the safety and efficacy of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant chemotherapy (NAC) before surgery \[neoadjuvant phase\], followed by pembrolizumab alone after surgery \[adjuvant phase\] in participants with resectable stage II, IIIA, and resectable IIIB (T3-4N2) non-small cell lung cancer (NSCLC). The primary hypotheses of this study are that neoadjuvant pembrolizumab (vs. placebo) in combination with NAC, followed by surgery and adjuvant pembrolizumab (vs. placebo) will improve: 1) event free survival (EFS) by biopsy assessed by local pathologist or by investigator-assessed imaging using Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1); and 2) overall survival (OS). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/14/2024
Locations: Banner MD Anderson Cancer Center ( Site 0028), Gilbert, Arizona +226 locations
Banner MD Anderson Cancer Center ( Site 0028), Gilbert, Arizona
Western Regional Medical Center, Inc. ( Site 0050), Goodyear, Arizona
University of Arizona Cancer Center - Dignity Health ( Site 0062), Phoenix, Arizona
University of Arizona Cancer Center ( Site 0012), Tucson, Arizona
Pacific Cancer Medical Center, Inc. ( Site 0004), Anaheim, California
Providence Saint Joseph Medical Center ( Site 0061), Burbank, California
Pacific Cancer Care ( Site 0035), Monterey, California
John Wayne Cancer Institute ( Site 0049), Santa Monica, California
St Joseph Heritage Healthcare ( Site 0040), Santa Rosa, California
Stanford University, Stanford Cancer Center ( Site 0046), Stanford, California
Hartford Hospital ( Site 0069), Hartford, Connecticut
Helen F. Graham Cancer Center & Research Institute ( Site 0015), Newark, Delaware
Mayo Clinic Jacksonville ( Site 0022), Jacksonville, Florida
Miami Cancer Institute-Baptist Hospital ( Site 0068), Miami, Florida
Southeastern Regional Medical Center ( Site 0051), Newnan, Georgia
Northwest Oncology and Hematology ( Site 0001), Elk Grove Village, Illinois
Ingalls Memorial Hospital ( Site 0044), Harvey, Illinois
PPG-Oncology ( Site 0043), Fort Wayne, Indiana
University of Iowa Hospital and Clinics ( Site 0010), Iowa City, Iowa
Ashland-Bellefonte Cancer Center ( Site 0021), Ashland, Kentucky
Harry & Jeanette Weinberg Cancer Institute ( Site 0081), Baltimore, Maryland
Boston Medical Center ( Site 0057), Boston, Massachusetts
UMass Memorial Medical Center ( Site 0030), Worcester, Massachusetts
Henry Ford Health System ( Site 0031), Detroit, Michigan
Herbert Herman Cancer Center, Sparrow Hospital ( Site 0034), Lansing, Michigan
Mayo Clinic ( Site 0026), Rochester, Minnesota
St. Vincent Healthcare Frontier Cancer Center ( Site 0005), Billings, Montana
University of Nebraska Medical Center ( Site 0047), Omaha, Nebraska
Memorial Sloan Kettering Cancer Center Basking Ridge ( Site 0074), Basking Ridge, New Jersey
Memorial Sloan Kettering Cancer Center- Monmouth ( Site 0077), Middletown, New Jersey
MSKCC-Bergen ( Site 0075), Montvale, New Jersey
St. Peter's Hospital Cancer Care Center ( Site 0039), Albany, New York
Montefiore Einstein Center ( Site 0016), Bronx, New York
Memorial Sloan-Kettering Cancer Center at Commack ( Site 0076), Commack, New York
Memorial Sloan Kettering Cancer Center Westchester ( Site 0079), Harrison, New York
Memorial Sloan Kettering Cancer Center ( Site 0060), New York, New York
Stony Brook University Medical Center - Cancer Center ( Site 0019), Stony Brook, New York
Memorial Sloan Kettering Cancer Center - Nassau ( Site 0078), Uniondale, New York
White Plains Hospital Center for Cancer Care ( Site 0007), White Plains, New York
Southwestern Regional Medical Center, Inc. ( Site 0054), Tulsa, Oklahoma
OHSU Center for Health & Healing ( Site 1006), Portland, Oregon
UPMC Pinnacle Health System - East Location ( Site 0063), Harrisburg, Pennsylvania
Cancer Treatment Centers of America-Eastern Regional Medical Center ( Site 0053), Philadelphia, Pennsylvania
Allegheny General Hospital ( Site 0009), Pittsburgh, Pennsylvania
UPMC Hillman Cancer Centers ( Site 0041), Pittsburgh, Pennsylvania
VA Pittsburgh Healthcare System ( Site 0052), Pittsburgh, Pennsylvania
Saint Francis Cancer Center ( Site 0096), Greenville, South Carolina
Emily Couric Clinical Cancer Center ( Site 0013), Charlottesville, Virginia
Inova Schar Cancer Institute ( Site 0032), Fairfax, Virginia
Virginia Cancer Specialists, PC ( Site 0080), Fairfax, Virginia
Providence Regional Cancer Partnership ( Site 0065), Everett, Washington
Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 0136), Berazategui, Buenos Aires
Hospital Privado de Comunidad. ( Site 0130), Mar del Plata, Buenos Aires
Hospital Universitario Austral ( Site 0127), Pilar, Buenos Aires
Fundacion Favaloro ( Site 0128), Ciudad de Buenos Aires, Caba
Sanatorio Britanico ( Site 0125), Rosario, Santa Fe
Sanatorio Parque ( Site 0135), Rosario, Santa Fe
Hospital Provincial del Centenario ( Site 0131), Rosario, Santa Fe
Hospital Privado Universitario de Córdoba ( Site 0139), Cordoba, Not set
Sanatorio Allende ( Site 0129), Cordoba, Not set
CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica ( Site 0133), San Juan, Not set
Orange Health Services ( Site 0624), Orange, New South Wales
Westmead Hospital ( Site 0621), Westmead, New South Wales
AZ Sint-Maarten ( Site 0226), Mechelen, Antwerpen
Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman ( Site 0223), Liège, Liege
UZ Gent ( Site 0224), Gent, Oost-Vlaanderen
AZ Nikolaas ( Site 0225), Sint-Niklaas, Oost-Vlaanderen
UZ Leuven ( Site 0221), Leuven, Vlaams-Brabant
AZ Delta ( Site 0222), Roeselare, West-Vlaanderen
Centro Regional Integrado de Oncologia ( Site 0160), Fortaleza, Ceara
Instituto do Cancer do Ceara ( Site 0152), Fortaleza, Ceara
Sirio-Libanes Brasilia - Centro de Oncologia - Asa Sul ( Site 0159), Brasilia, Distrito Federal
Liga Norte Riograndense Contra o Cancer ( Site 0150), Natal, Rio Grande Do Norte
Hospital de Caridade de Ijui ( Site 0153), Ijui, Rio Grande Do Sul
Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 0146), Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceicao ( Site 0145), Porto Alegre, Rio Grande Do Sul
YNOVA Pesquisa Clinica ( Site 0823), Florianopolis, Santa Catarina
Fundacao Pio XII - Hospital de Cancer de Barretos ( Site 0144), Barretos, Sao Paulo
Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0149), Rio de Janeiro, Not set
Hospital Paulistano - Amil Clinical Research ( Site 0822), Sao Paulo, Not set
Hospital Alemao Oswaldo Cruz ( Site 0158), Sao Paulo, Not set
Princess Margaret Cancer Centre ( Site 0109), Toronto, Ontario
CIUSSS du Saguenay-Lac-St-Jean ( Site 0101), Chicoutimi, Quebec
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0110), Montreal, Quebec
CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0104), Montreal, Quebec
McGill University Health Centre ( Site 0111), Montreal, Quebec
Tianjin Medical University General Hospital ( Site 0806), Tianjin, Anhui
Beijing Cancer Hospital ( Site 0810), Beijing, Beijing
Beijing Cancer Hospital ( Site 0811), Beijing, Beijing
Cancer Hospital Chinese Academy of Medical Sciences ( Site 0801), Beijing, Beijing
Peking University Third Hospital ( Site 0812), Beijing, Beijing
Peking Union Medical College Hospital ( Site 0809), Beijing, Beijing
Sun Yat-Sen University Cancer Center ( Site 0816), Guangzhou, Guangdong
Hunan Cancer Hospital ( Site 0815), Changsha, Hunan
Fudan University Shanghai Cancer Center ( Site 0813), Shanghai, Shanghai
Zhongshan Hospital of Fudan University ( Site 0808), Shanghai, Shanghai
Shanghai Pulmonary Hospital-Thoracic Surgery department ( Site 0817), Shanghai, Shanghai
Tang Du Hospital ( Site 0803), XI An, Shanxi
The First Affiliated Hospital of Zhejiang University ( Site 0804), Hangzhou, Zhejiang
Zhejiang Cancer Hospital.... ( Site 0814), Hangzhou, Zhejiang
Hwa Mei Hospital University of Chinese Academy of Sciences ( Site 0802), Ningbo, Zhejiang
SA Pohja-Eesti Regionaalhaigla ( Site 1100), Tallinn, Harjumaa
Hopital Foch ( Site 0243), Suresnes, Ain
Nouvel Hopital Civil ( Site 0255), Strasbourg, Bas-Rhin
CHU de Toulouse - Hopital Larrey ( Site 0258), Toulouse, Haute-Garonne
Clinique Francois Chenieux ( Site 0246), Limoges, Haute-Vienne
Hospices Civils de Lyon Centre Hospitalier Lyon Sud ( Site 0241), Pierre-Benite, Rhone-Alpes
Centre Hospitalier Metropole Savoie Site de Chambery ( Site 0245), Chambery, Savoie
Centre Hospitalier Annecy Genevois ( Site 0242), Pringy, Savoie
CHU de Rouen ( Site 0252), Rouen, Seine-Maritime
Hôpital Avicenne - Service d oncologie medicale ( Site 0249), Bobigny, Seine-Saint-Denis
H.I.A. Sainte-Anne ( Site 0251), Toulon, Var
Institut Curie ( Site 0250), Paris, Not set
Klinikum Esslingen GmbH ( Site 0875), Esslingen, Baden-Wurttemberg
LKI Lungenfachklinik Immenhausen ( Site 0268), Immenhausen, Hessen
Florence Nightingale Krankenhaus ( Site 0874), Duesseldorf, Nordrhein-Westfalen
Lungenklinik Hemer ( Site 0269), Hemer, Nordrhein-Westfalen
Mathias Spital Rheine ( Site 0261), Rheine, Nordrhein-Westfalen
Katholisches Klinikum Koblenz Haus Marienhof ( Site 0873), Koblenz, Rheinland-Pfalz
Universitaetsklinikum Carl Gustav Carus ( Site 0273), Dresden, Sachsen
Universitaetsklinikum Leipzig AOeR ( Site 0277), Leipzig, Sachsen
LungenClinic Grosshansdorf GmbH ( Site 0267), Grosshansdorf, Schleswig-Holstein
Universitaetsklinikum Schleswig Holstein ( Site 0871), Kiel, Schleswig-Holstein
Zentralklinik Bad Berka GmbH ( Site 0264), Bad Berka, Thuringen
SRH Waldklinikum Gera GmbH ( Site 0272), Gera, Thuringen
Evangelische Lungenklinik Berlin ( Site 0274), Berlin, Not set
HELIOS Klinikum Emil von Behring ( Site 0280), Berlin, Not set
Asklepios Klinikum Hamburg ( Site 0271), Hamburg, Not set
Cork University Hospital ( Site 0452), Wilton, Cork
St James Hospital ( Site 0451), Dublin, Not set
Mid Western Cancer Centre ( Site 0450), Limerick, Not set
Istituto Nazionale Tumori ( Site 0309), Milano, Abruzzo
Azienda Ospedaliera dei Colli V. Monaldi ( Site 0301), Napoli, Campania
IRST-Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori ( Site 0300), Meldola, Forli-Cesena
Istituto Clinico Humanitas Research Hospital ( Site 0314), Rozzano, Lombardia
ASST Grande Ospedale Metropolitano Niguarda-Oncologia Falck ( Site 0315), Milan, Milano
Azienda Ospedaliera San Gerardo ( Site 0308), Monza, Monza E Brianza
AOU San Luigi Gonzaga di Orbassano ( Site 0313), Orbassano, Torino
Azienda Ospedaliera Spedali Civili di Brescia ( Site 0307), Brescia, Not set
IRCCS Ospedale San Raffaele di Milano ( Site 0303), Milano, Not set
Azienda Ospedaliera San Camillo Forlanini ( Site 0311), Roma, Not set
Aichi Cancer Center Hospital ( Site 0765), Nagoya, Aichi
National Cancer Center Hospital East ( Site 0761), Kashiwa, Chiba
HP of the Univ. of Occupational and Environmental Health, Japan ( Site 0770), Kitakyushu, Fukuoka
Hyogo Cancer Center ( Site 0764), Akashi, Hyogo
St. Marianna University School of Medicine Hospital ( Site 0769), Kawasaki, Kanagawa
Kanagawa Cancer Center ( Site 0763), Yokohama, Kanagawa
Oita University Hospital ( Site 0766), Yufu, Oita
Fukushima Medical University Hospital ( Site 0772), Fukushima, Not set
Hiroshima University Hospital ( Site 0762), Hiroshima, Not set
National Cancer Center Hospital ( Site 0767), Tokyo, Not set
Juntendo University Hospital ( Site 0768), Tokyo, Not set
Tokyo Medical University Hospital ( Site 0771), Tokyo, Not set
National Cancer Center ( Site 0702), Gyeonggi-do, Kyonggi-do
The Catholic University of Korea St. Vincent s Hospital ( Site 0705), Gyeonggi-do, Kyonggi-do
Asan Medical Center ( Site 0701), Seoul, Not set
Samsung Medical Center ( Site 0704), Seoul, Not set
SMG-SNU Boramae Medical Center ( Site 0707), Seoul, Not set
Pauls Stradins Clinical University Hospital ( Site 0911), Riga, Not set
Riga East Clinical University Hospital ( Site 0912), Riga, Not set
LSMUL Kauno Klinikos ( Site 0932), Kaunas, Not set
Nacionalinis Vezio Institutas ( Site 0931), Vilnius, Not set
Sarawak General Hospital ( Site 0782), Kuching, Sarawak
University Malaya Medical Centre ( Site 0781), Kuala Lumpur, Not set
Centrum Pulmonologii i Torakochirurgii w Bystrej ( Site 0484), Bystra, Dolnoslaskie
Dolnoslaskie Centrum Onkologii. ( Site 0491), Wroclaw, Dolnoslaskie
Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 0488), Bydgoszcz, Kujawsko-pomorskie
Wojewodzki Szpital Specjalistyczny im. M. Kopernika w Lodzi ( Site 0493), Lodz, Lodzkie
Szpital Specjalistyczny w Prabutach Sp. z o.o. ( Site 0483), Prabuty, Pomorskie
Wielkopolskie Centrum Pulmonologii i Torakochirurgii ( Site 0487), Poznan, Wielkopolskie
S C Pelican Impex SRL ( Site 0506), Oradea, Bihor
Centrul Medical Medicover Victoria ( Site 0514), Bucharest, Bucuresti
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 0501), Cluj Napoca, Cluj
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 0515), Cluj-Napoca, Cluj
SC Radiotherapy Center Cluj SRL ( Site 0509), Comuna Floresti, Cluj
S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 0504), Craiova, Dolj
S.C.R.T.C.Radiology Therapeutic Center SRL ( Site 0511), Otopeni, Ilfov
S C Oncocenter Oncologie Medicala S R L ( Site 0505), Timisoara, Timis
Spitalul Sf. Constantin ( Site 0512), Brasov, Not set
Euroclinic Hospital Bucharest ( Site 0510), Bucuresti, Not set
S.C.Focus Lab Plus S.R.L ( Site 0513), Bucuresti, Not set
Spitalul clinic Judetean de urgenta Constanta ( Site 0508), Constanta, Not set
Spitalul Judetean de Urgenta .Sf. Ioan cel Nou. ( Site 0503), Suceava, Not set
Chelyabinsk Regional Clinical Oncological Dispensary ( Site 0530), Chelyabinsk, Chelyabinskaya Oblast
N.N. Blokhin NMRCO ( Site 0521), Moscow, Moskva
National Medical Research Radiology Centre ( Site 0535), Moscow, Moskva
Medical Rehabilitation Center ( Site 0534), Moscow, Moskva
SBHI Leningrad Regional Clinical Hospital ( Site 0524), Saint Petersburg, Sankt-Peterburg
Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 0533), Saint Petersburg, Sankt-Peterburg
Municipal Clinical Oncology Center ( Site 0523), Saint Petersburg, Sankt-Peterburg
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0529), Kazan, Tatarstan, Respublika
Tomsk Scientific Research Institute of Oncology ( Site 0526), Tomsk, Tomskaya Oblast
Wits Clinical Research ( Site 0570), Parktown-Johannesburg, Gauteng
Wilgers Oncology Centre ( Site 0573), Pretoria, Gauteng
The Oncology Centre ( Site 0571), Durban, Kwazulu-Natal
Cape Town Oncology Trials Pty Ltd ( Site 0572), Kraaifontein, Western Cape
Hospital Germans Trias i Pujol. ICO de Badalona ( Site 0381), Badalona, Barcelona
Instituto Catalan de Oncologia - ICO ( Site 0388), L Hospitalet De Llobregat, Barcelona
Hospital Universitario de Girona Doctor Josep Trueta ( Site 0386), Girona, La Coruna
Hospital Universitario Insular de Gran Canaria ( Site 0383), Las Palmas de Gran Canaria, Las Palmas
Hospital de la Santa Creu i Sant Pau ( Site 0385), Barcelona, Not set
Hospital Universitari Vall d Hebron ( Site 0389), Barcelona, Not set
Hospital General Universitario Gregorio Maranon ( Site 0382), Madrid, Not set
Hospital Virgen del Rocio ( Site 0387), Sevilla, Not set
Kaohsiung Chang Gung Memorial Hospital ( Site 0725), Kaohsiung, Not set
China Medical University Hospital ( Site 0724), Taichung, Not set
National Taiwan University Hospital ( Site 0721), Taipei, Not set
Taipei Veterans General Hospital ( Site 0722), Taipei, Not set
Tri-Service General Hospital ( Site 0726), Taipei, Not set
Chang Gung Medical Foundation.Linkou Branch ( Site 0723), Taoyuan, Not set
Cherkassy Regional Oncological Center ( Site 0613), Cherkasy, Cherkaska Oblast
City Clinical Hosp.4 of DCC ( Site 0607), Dnipro, Dnipropetrovska Oblast
MI Precarpathian Clinical Oncology Center ( Site 0603), Ivano-Frankivsk, Ivano-Frankivska Oblast
MI KhRC Kherson Regional Oncology Dispensary ( Site 0614), Kherson, Khersonska Oblast
PP PPC Acinus Medical and Diagnostic Centre ( Site 0609), Kropyvnytsky, Kirovohradska Oblast
National Cancer Institute of the MoH of Ukraine ( Site 0605), Kyiv, Kyivska Oblast
Kyiv City Clinical Oncological Center ( Site 0601), Kyiv, Kyivska Oblast
MI Odessa Regional Oncological Centre ( Site 0608), Odesa, Odeska Oblast
Zaporizhzhya Regional Clinical Oncology Center ( Site 0606), Zaporizhzhya, Zaporizka Oblast
Leicester Royal Infirmary ( Site 0447), Leicester, Leicestershire
The Clatterbridge Cancer Centre NHS Foundation Trust ( Site 0456), Wirral, Liverpool
Royal Marsden NHS Foundation Trust ( Site 0458), London, London, City Of
Royal Marsden Hospital ( Site 0457), Sutton, London, City Of
Nottingham City Hospital Campus ( Site 0441), Nottingham, Nottinghamshire
Heartlands Hospital in Birmingham ( Site 0455), Birmingham, Not set
Freeman Hospital ( Site 0444), Newcastle upon Tyne, Not set
Plymouth Hospitals NHS Trust ( Site 0443), Plymouth, Not set
Conditions: Non-small Cell Lung Cancer
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
Active Not Recruiting
The purpose of this study is to assess the efficacy and safety of treatment with definitive chemoradiotherapy (dCRT) + pembrolizumab (MK-3475) compared to treatment with dCRT + placebo with respect to Event-free Survival (EFS) and Overall Survival (OS) in:
* participants whose tumors express Programmed Death-Ligand 1 (PD-L1) Combined Positive Score (CPS) ≥10
* participants whose tumors express PD-L1 CPS ≥1
* all participants
The primary study hypotheses are that dCRT+ pembrolizumab is better t... Read More
The purpose of this study is to assess the efficacy and safety of treatment with definitive chemoradiotherapy (dCRT) + pembrolizumab (MK-3475) compared to treatment with dCRT + placebo with respect to Event-free Survival (EFS) and Overall Survival (OS) in:
* participants whose tumors express Programmed Death-Ligand 1 (PD-L1) Combined Positive Score (CPS) ≥10
* participants whose tumors express PD-L1 CPS ≥1
* all participants
The primary study hypotheses are that dCRT+ pembrolizumab is better than dCRT + placebo with respect to:
* EFS in participants whose tumors express PD-L1 CPS ≥10
* EFS in participants whose tumors express PD-L1 CPS ≥1
* EFS in all participants
* OS in participants whose tumors express PD-L1 CPS ≥10
* OS in participants whose tumors express PD-L1 CPS ≥1
* OS in all participants Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/13/2024
Locations: MemorialCare Health System - Long Beach Medical Center-Oncology ( Site 0691), Long Beach, California +169 locations
MemorialCare Health System - Long Beach Medical Center-Oncology ( Site 0691), Long Beach, California
Columbus Regional Research Institute ( Site 0047), Columbus, Georgia
University of Kansas Cancer Center ( Site 0023), Westwood, Kansas
Cancer Center of Kansas ( Site 0058), Wichita, Kansas
University Medical Center ( Site 0035), New Orleans, Louisiana
Greater Baltimore Medical Center ( Site 0031), Baltimore, Maryland
Dana Farber Cancer Center ( Site 0034), Boston, Massachusetts
Henry Ford Hospital ( Site 0685), Detroit, Michigan
University of Missouri ( Site 0688), Columbia, Missouri
Renown Regional Medical Center ( Site 0706), Reno, Nevada
Rutgers Cancer Institute of New Jersey ( Site 0695), New Brunswick, New Jersey
Weill Cornell Medical College ( Site 0053), New York, New York
Stephenson Cancer Center ( Site 0044), Oklahoma City, Oklahoma
Oregon Health & Science University Center for Health & Healing 2- CHH2 ( Site 0060), Portland, Oregon
Allegheny Health Network ( Site 0042), Pittsburgh, Pennsylvania
Thompson Cancer Survival Center ( Site 0696), Knoxville, Tennessee
Utah Cancer Specialists ( Site 0697), Salt Lake City, Utah
Cancer Care Northwest - Spokane Valley ( Site 0036), Spokane Valley, Washington
University of Wisconsin Hospital and Clinics ( Site 0033), Madison, Wisconsin
Instituto Medico Alexander Fleming ( Site 0063), Buenos Aires, Caba
Fundacion Favaloro ( Site 0061), Ciudad de Buenos Aires, Caba
Hospital Municipal de Gastroenterologia Dr. Bonorino Udaondo ( Site 0066), Buenos Aires, Not set
CEMIC ( Site 0064), Buenos Aires, Not set
UCL Saint Luc ( Site 0162), Brussels, Bruxelles-Capitale, Region De
UZ Gent ( Site 0163), Gent, Oost-Vlaanderen
UZ Leuven ( Site 0161), Leuven, Vlaams-Brabant
AZ Delta ( Site 0165), Roeselare, West-Vlaanderen
ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 0088), Ijui, Rio Grande Do Sul
Hospital Nossa Senhora da Conceicao ( Site 0087), Porto Alegre, Rio Grande Do Sul
Clinica de Oncologia Reichow ( Site 0085), Blumenau, Santa Catarina
Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 0081), Sao Paulo, Not set
Cross Cancer Institute ( Site 0010), Edmonton, Alberta
CancerCare Manitoba ( Site 0002), Winnipeg, Manitoba
The Ottawa Hospital - Cancer Care ( Site 0008), Ottawa, Ontario
Sunnybrook Research Institute ( Site 0012), Toronto, Ontario
Princess Margaret Cancer Centre ( Site 0011), Toronto, Ontario
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0005), Montreal, Quebec
Centro Investigación del Cáncer James Lind ( Site 0106), Temuco, Araucania
Centro de Investigacion y desarrollo Oncologico SpA - CIDO SpA ( Site 0103), Temuco, Araucania
Hospital Regional de Concepcion ( Site 0105), Concepcion, Biobio
Centro de Cancer Nuestra Senora de la Esperanza ( Site 0104), Santiago, Region M. De Santiago
Anhui Provincial Hospital-Oncology Radiotherapy Department ( Site 0531), Hefei, Anhui
The 900th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army ( Si, Fuzhou, Fujian
The First Affiliated Hospital of Xiamen University ( Site 0538), Xiamen, Fujian
Hubei Cancer Hospital ( Site 0514), Wuhan, Hubei
Hunan Cancer Hospital ( Site 0515), Changsha, Hunan
Huai an First People s Hospital ( Site 0526), Huai An, Jiangsu
Jiangsu Cancer Hospital ( Site 0519), Nanjing, Jiangsu
The Affiliated Hospital of Xuzhou Medical University ( Site 0522), Xuzhou, Jiangsu
Affiliated Hospital of Jiangsu University ( Site 0524), Zhenjiang, Jiangsu
Jiangxi Cancer Hospital ( Site 0512), Nanchang, Jiangxi
Shanghai Chest Hospital ( Site 0503), Shangai, Shanghai
Shanghai Chest Hospital ( Site 0501), Shanghai, Shanghai
Zhongshan Hospital Fudan University ( Site 0502), Shanghai, Shanghai
Sichuan Cancer Hospital ( Site 0527), Chengdu, Sichuan
Tianjin Medical University Cancer Institute & Hospital ( Site 0505), Tianjin, Tianjin
Hangzhou First People's Hospital ( Site 0530), Hangzhou, Zhejiang
Sir Run Run Shaw Hospital ( Site 0523), Hangzhou, Zhejiang
Zhejiang Cancer Hospital ( Site 0529), Hangzhou, Zhejiang
Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0721), Brno, Brno-mesto
Fakultni nemocnice Ostrava-Klinika onkologicka ( Site 0719), Ostrava, Moravskoslezsky Kraj
Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0720), Olomouc, Olomoucky Kraj
Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 0718), Praha, Praha 5
Rigshospitalet ( Site 0199), Copenhagen, Hovedstaden
Odense Universitetshospital ( Site 0200), Odense, Syddanmark
SA Pohja-Eesti Regionaalhaigla ( Site 0201), Tallinn, Harjumaa
SA Tartu Ulikooli Kliinikum ( Site 0202), Tartu, Tartumaa
Institut De Cancerologie De Lorraine ( Site 0222), Vandoeuvre les Nancy, Ain
Centre Francois Baclesse ( Site 0236), Caen, Calvados
Centre Georges Francois Leclerc ( Site 0223), Dijon, Cote-d Or
CHU Limoges Hopital Dupuytren ( Site 0225), Limoges, Haute-Vienne
Institut Curie - Centre Rene Huguenin ( Site 0237), Saint-Cloud, Hauts-de-Seine
Institut Jean Godinot ( Site 0238), Reims, Marne
CHU Hotel Dieu Nantes ( Site 0230), Nantes, Pays-de-la-Loire
Institut Sainte Catherine ( Site 0228), Avignon, Provence-Alpes-Cote-d Azur
CHU Amiens Picardie Site Sud Amiens ( Site 0235), Amiens, Somme
CHD Vendee ( Site 0227), La Roche sur Yon, Vendee
Marienhospital Stuttgart Vincenz von Paul Kliniken gGmbH ( Site 0253), Stuttgart, Baden-Wurttemberg
Universitaetsklinikum Koeln ( Site 0251), Koeln, Nordrhein-Westfalen
Universitaetsklinikum Muenster ( Site 0248), Muenster, Nordrhein-Westfalen
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz ( Site 0247), Mainz, Rheinland-Pfalz
Charite Campus Virchow Klinikum ( Site 0250), Berlin, Not set
Facharztzentrum Eppendorf ( Site 0242), Hamburg, Not set
Centro de Investigaciones Clinicas de Latinoamerica S.A. - CELAN ( Site 0122), Guatemala, Not set
Gastrosoluciones ( Site 0126), Guatemala, Not set
Oncomedica ( Site 0125), Guatemala, Not set
Grupo Medico Angeles ( Site 0121), Guatemala, Not set
Medi-K Cayala ( Site 0124), Guatemala, Not set
Centro Medico Integral De Cancerología (CEMIC) ( Site 0123), Quetzaltenango, Not set
Pamela Youde Nethersole Eastern Hospital ( Site 0543), Hong Kong, Not set
Princess Margaret Hospital. ( Site 0542), Hong Kong, Not set
Queen Mary Hospital ( Site 0541), Pokfulam, Not set
Pecsi Tudomanyegyetem AOK ( Site 0265), Pecs, Baranya
Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 0262), Gyula, Bekes
Orszagos Onkologiai Intezet ( Site 0263), Budapest, Not set
Debreceni Egyetem Klinikai Kozpont ( Site 0261), Debrecen, Not set
Fondazione IRCCS Policlinico San Matteo-Oncology ( Site 0300), Pavia, Lombardia
IRCCS Policlinico San Donato ( Site 0295), San Donato Milanese, Milano
Azienda Ospedaliero Universitaria Pisana - Presidio Santa Chiara ( Site 0294), Pisa, Toscana
ASST Papa Giovanni XXIII ( Site 0296), Bergamo, Not set
Azienda Socio Sanitaria Territoriale di Cremona ( Site 0299), Cremona, Not set
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0292), Milano, Not set
Istituto Nazionale Tumori IRCCS Fondazione Pascale-SC Oncologia Clinica Sperimentale Addome ( Site 0, Napoli, Not set
IRCCS Istituto Oncologico Veneto ( Site 0298), Padova, Not set
Policlinico Universitario A. Gemelli ( Site 0297), Roma, Not set
Aichi Cancer Center Hospital ( Site 0563), Nagoya, Aichi
National Cancer Center Hospital East ( Site 0562), Kashiwa, Chiba
Kanagawa Cancer Center ( Site 0565), Yokohama, Kanagawa
Saitama Cancer Center ( Site 0564), Kitaadachi-gun, Saitama
Shizuoka Cancer Center Hospital and Research Institute ( Site 0566), Sunto-gun, Shizuoka
National Cancer Center Hospital ( Site 0561), Tokyo, Not set
Chonnam National University Hwasun Hospital ( Site 0625), Hwasun Gun, Jeonranamdo
National Cancer Center ( Site 0626), Goyang-si, Kyonggi-do
Asan Medical Center ( Site 0623), Songpagu, Seoul
Severance Hospital Yonsei University Health System ( Site 0624), Seoul, Not set
Samsung Medical Center ( Site 0622), Seoul, Not set
Korea University Guro Hospital ( Site 0621), Seoul, Not set
Cryptex Investigación Clínica S.A. de C.V. ( Site 0729), Cuauhtémoc, Ciudad De México, Distrito Federal
CENTRO HEMATO ONCOLOGICO PRIVADO-CHOP ( Site 0728), Toluca de Lerdo, Not set
Instituto Nacional de Enfermedades Neoplasicas ( Site 0141), Lima, Muni Metro De Lima
Detecta Clínica ( Site 0146), Surquillo, Muni Metro De Lima
Hospital Nacional Arzobispo Loayza ( Site 0143), Lima, Not set
Clinica San Gabriel ( Site 0142), Lima, Not set
Baguio General Hospital and Medical Center ( Site 0603), Baguio City, Benguet
Cebu Doctors University Hospital ( Site 0604), Cebu City, Cebu
The Medical City-Iloilo ( Site 0602), Iloilo City, Iloilo
St. Luke s Medical Center ( Site 0601), Quezon, National Capital Region
Hospital Beatriz Angelo ( Site 0374), Loures, Lisboa
Inst. Portugues de Oncologia de Lisboa Francisco Gentil EPE ( Site 0372), Lisboa, Not set
Hospital da Luz ( Site 0373), Lisboa, Not set
CHLN Hospital Santa Maria ( Site 0376), Lisboa, Not set
Inst. Portugues de Oncologia de Porto Francisco Gentil EPE ( Site 0371), Porto, Not set
MedEuropa Bucuresti - Centru de Radioterapie-Oncology ( Site 0400), București, Bucuresti
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 0392), Cluj-Napoca, Cluj
S.C. Radiotherapy Center Cluj S.R.L ( Site 0391), Cluj-Napoca, Cluj
Ovidius Clinical Hospital OCH-Oncology and Hematology ( Site 0393), Ovidiu, Constanta
S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 0394), Craiova, Dolj
Centrul Medical Topmed ( Site 0398), Targu-Mures, Mures
S.C.Focus Lab Plus S.R.L ( Site 0395), Bucuresti, Not set
GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 0430), Ufa, Baskortostan, Respublika
Kaluga Regional Clinical Oncology Center ( Site 0424), Kaluga, Kaluzskaja Oblast
Main Military Clinical Hospital n.a. N.N.Burdenko ( Site 0421), Moscow, Moskva
FSAI Treatment and Rehabilitation Centre of the MoH and SD of RF ( Site 0429), Moscow, Moskva
SBHI Samara Regional Clinical Oncology Dispensary ( Site 0420), Samara, Samarskaya Oblast
Pavlov First Saint Petersburg State Medical University ( Site 0426), St. Petersburg, Sankt-Peterburg
Medical institute named after Berezin Sergey ( Site 0417), St. Petersburg, Sankt-Peterburg
Sverdlovsk Regional Oncology Hospital ( Site 0411), Ekaterinburg, Sverdlovskaya Oblast
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0412), Kazan, Tatarstan, Respublika
Chang Gung Med Foundation. Kaohsiung Branch ( Site 0643), Kaohsiung, Not set
China Medical University Hospital ( Site 0646), Taichung, Not set
Taichung Veterans General Hospital-Radiation Oncology ( Site 0647), Taichung, Not set
National Cheng Kung University Hospital ( Site 0645), Tainan, Not set
National Taiwan University Hospital ( Site 0641), Taipei, Not set
Koo Foundation Sun Yat-Sen Cancer Center ( Site 0644), Taipei, Not set
Chang Gung Medical Foundation. Linkou ( Site 0642), Taoyuan, Not set
Istanbul University Cerrahpasa Medical Faculty ( Site 0452), Istambul, Istanbul
Memorial Ankara Hastanesi ( Site 0461), Ankara, Not set
Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 0451), Istanbul, Not set
Ege Universitesi Tip Fakultesi ( Site 0457), Izmir, Not set
Izmir Katip Celebi Universitesi Ataturk Egitim ve Arastirma Hastanesi ( Site 0458), Izmir, Not set
Aberdeen Royal Infirmary ( Site 0474), Aberdeen, Aberdeen City
Cambridge University Hospitals NHS Trust ( Site 0477), Cambridge, Cambridgeshire
Royal Free Hospital ( Site 0702), London, England
ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 0283), London, London, City Of
Hammersmith Hospital-Medical Oncology ( Site 0471), London, London, City Of
Nottingham University Hospitals NHS Trust ( Site 0476), Nottingham, Nottinghamshire
Royal Marsden Hospital (Sutton) ( Site 0281), Sutton, Surrey
University College Hospital NHS Foundation Trust ( Site 0701), London, Worcestershire
The Christie NHS Foundation Trust ( Site 0282), Manchester, Not set
Mount Vernon Hospital ( Site 0478), Northwood, Not set
Conditions: Esophageal Squamous Cell Carcinoma (ESCC), Esophageal Adenocarcinoma (EAC), Gastroesophageal Junction Carcinoma (GEJC)
121 - 132 of 326